{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":602,"total_is_capped":false,"direct_labels_cover":1,"predictions_cover":602,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"386b2f745ddd","filters":{"venue":"Diabetes Obesity and Metabolism"}},"results":[{"id":"W4224218205","doi":"10.1111/dom.14725","title":"Weight regain and cardiometabolic effects after withdrawal of semaglutide: The <scp>STEP</scp> 1 trial extension","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":921,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"McMaster University; York University","funders":"Novo Nordisk; National Institute for Health and Care Research","keywords":"Semaglutide; Medicine; Placebo; Weight loss; Body mass index; Randomized controlled trial; Internal medicine; Physical therapy; Diabetes mellitus; Obesity; Type 2 diabetes; Endocrinology","authors":[{"name":"John Wilding","is_ca":false},{"name":"Rachel L. Batterham","is_ca":false},{"name":"Melanie J. Davies","is_ca":false},{"name":"Luc F. Van Gaal","is_ca":false},{"name":"Kristian Kandler","is_ca":false},{"name":"Katerina Konakli","is_ca":false},{"name":"Ildiko Lingvay","is_ca":false},{"name":"Barbara McGowan","is_ca":false},{"name":"Tuğçe Kalaycı Oral","is_ca":false},{"name":"Julio Rosenstock","is_ca":false},{"name":"Thomas A. Wadden","is_ca":false},{"name":"Sean Wharton","is_ca":true},{"name":"Koutaro Yokote","is_ca":false},{"name":"Robert F. Kushner","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005126095142822623,"gpt":0.2057054038277823,"spread":0.2005793086849597,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001903503,0.0007605025,0.001164656,0.0001760102,0.0002398659,0.000560077,0.0004015719,0.0007464525,0.005161243],"category_scores_gemma":[0.001839597,0.0002244023,0.001203302,0.0001764759,0.0002762464,0.0003839594,0.0004086839,0.001517532,0.0005613886],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000280505,"about_ca_system_score_gemma":0.0009128638,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005267351,"about_ca_topic_score_gemma":0.001693407,"domain_scores_codex":[0.9995068,0.0002914852,0.00003526041,0.00005087338,0.00005161448,0.00006390305],"domain_scores_gemma":[0.9989936,0.0002676771,0.000306557,0.0001011718,0.0001282244,0.0002028074],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8993573,0.01003128,0.009647419,0.002147154,0.00179128,0.0001826135,0.0002108779,0.000475928,0.008643096,0.0001529331,0.00348625,0.06387395],"study_design_scores_gemma":[0.6255878,0.2940812,0.06779289,0.0003721348,0.002688106,0.0003474614,0.0001460944,0.0007872334,0.002732448,0.0003576168,0.005061578,0.00004547954],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932934,0.001513117,0.0002312928,0.0002409493,0.00009041114,0.001802146,0.001182714,0.00003494017,0.001610988],"genre_scores_gemma":[0.9881761,0.001290243,0.0009537665,0.000531616,0.0001588953,0.003637349,0.002059056,0.00002072623,0.003172277],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005161243,"threshold_uncertainty_score":0.01726609,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2077038286","doi":"10.1111/dom.12090","title":"Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease","year":2013,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":486,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"Mitsubishi Tanabe Pharma Corporation; European Foundation for the Study of Diabetes; American Society of Nephrology; American Diabetes Association","keywords":"Canagliflozin; Medicine; Renal function; Placebo; Kidney disease; Internal medicine; Type 2 diabetes; Urology; Diabetes mellitus; Creatinine; Endocrinology; Empagliflozin; Blood urea nitrogen; Gastroenterology","authors":[{"name":"J.‐F. Yale","is_ca":true},{"name":"George L. Bakris","is_ca":false},{"name":"Bertrand Cariou","is_ca":false},{"name":"Dennis K. Yue","is_ca":false},{"name":"Elias David‐Neto","is_ca":false},{"name":"Liwen Xi","is_ca":false},{"name":"K. Figueroa","is_ca":false},{"name":"Ewa Wajs","is_ca":false},{"name":"Keith Usiskin","is_ca":false},{"name":"Gary Meininger","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005145271682165609,"gpt":0.2017799933368106,"spread":0.196634721654645,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002030119,0.0002825575,0.001096538,0.0002239841,0.0001890322,0.0004309285,0.000222211,0.0006128878,0.001504052],"category_scores_gemma":[0.001656453,0.0001197143,0.0006559585,0.0002624882,0.0003202091,0.0002417274,0.0001638475,0.0009062004,0.0001869344],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003002177,"about_ca_system_score_gemma":0.0004839875,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005276282,"about_ca_topic_score_gemma":0.000886404,"domain_scores_codex":[0.9995337,0.0002078761,0.00004340358,0.00006675017,0.0001094071,0.00003899486],"domain_scores_gemma":[0.9992361,0.0002803196,0.0002425596,0.00003691962,0.00006534913,0.0001387222],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6842289,0.01292183,0.04988523,0.001458612,0.002052071,0.0001996573,0.0001635403,0.001135744,0.02047012,0.0001100275,0.001936918,0.2254373],"study_design_scores_gemma":[0.3006301,0.394167,0.2828598,0.0002619204,0.003343084,0.0007379056,0.0001298711,0.003232187,0.008966739,0.0003318356,0.005288179,0.00005139695],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880219,0.009223971,0.0003787315,0.0002851771,0.00008951674,0.0003333259,0.0002530059,0.00003554216,0.001378906],"genre_scores_gemma":[0.9962739,0.001836916,0.0005111357,0.0003742019,0.0001600986,0.0001769173,0.0003221174,0.000003868679,0.0003408502],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002030119,"threshold_uncertainty_score":0.01073641,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3129758593","doi":"10.1111/dom.14290","title":"Obesity as a <scp>multisystem</scp> disease: Trends in obesity rates and <scp>obesity‐related</scp> complications","year":2021,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":408,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Addiction and Mental Health; Diabetes Canada; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Obesity; Prediabetes; Weight loss; Type 2 diabetes; Disease; Body mass index; Diabetes mellitus; Comorbidity; Gerontology; Intensive care medicine; Internal medicine; Endocrinology","authors":[{"name":"Shohinee Sarma","is_ca":true},{"name":"Sanjeev Sockalingam","is_ca":true},{"name":"Satya Dash","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02595724363166819,"gpt":0.3007374094411744,"spread":0.2747801658095063,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006142164,0.0006505341,0.001098157,0.003263184,0.0002590031,0.001106396,0.0005994264,0.0008762234,0.004756931],"category_scores_gemma":[0.001441113,0.0001940893,0.001119185,0.003391986,0.0003146035,0.001060362,0.0006321721,0.001422347,0.001205902],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007793847,"about_ca_system_score_gemma":0.001859276,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003113157,"about_ca_topic_score_gemma":0.005298224,"domain_scores_codex":[0.9996705,0.00006478456,0.00005837123,0.00004613213,0.000125475,0.0000347091],"domain_scores_gemma":[0.999353,0.000338023,0.0001135093,0.00001434633,0.0001404693,0.00004062029],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007999392,0.0000496857,0.0006923045,0.05658861,0.0003467237,0.0001303613,0.0001150255,0.0003129008,0.0005416163,0.004019123,0.04980166,0.8873221],"study_design_scores_gemma":[0.00002013307,0.00009064985,0.004802073,0.04581789,0.000587526,0.001619243,0.0001709065,0.0001511118,0.000209577,0.002378859,0.9441255,0.00002641634],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001264411,0.9982302,0.0000515788,0.0004850451,0.000214074,0.000004443278,0.00004686818,0.000006686142,0.0008348231],"genre_scores_gemma":[0.0006249694,0.9986199,0.00009720803,0.0002216099,0.0001072418,0.000004366191,0.00004619973,0.000001472743,0.0002770256],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004756931,"threshold_uncertainty_score":0.01591349,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2051243940","doi":"10.1111/dom.12188","title":"Empagliflozin improves glycaemic and weight control as add‐on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24‐week, randomized, placebo‐controlled trial","year":2013,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":383,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Empagliflozin; Metformin; Pioglitazone; Placebo; Medicine; Type 2 diabetes; Tolerability; Internal medicine; Clinical endpoint; Urology; Diabetes mellitus; Adverse effect; Randomized controlled trial; Gastroenterology; Endocrinology","authors":[{"name":"Christopher S. Kovács","is_ca":true},{"name":"V Seshiah","is_ca":false},{"name":"Ros Swallow","is_ca":false},{"name":"Russell Jones","is_ca":false},{"name":"H. Rattunde","is_ca":false},{"name":"Hans J. Woerle","is_ca":false},{"name":"Uli C. Broedl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006671166235841569,"gpt":0.2134640705234327,"spread":0.2067929042875911,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002052417,0.001333539,0.003151659,0.000509139,0.0003812845,0.00103002,0.0008753542,0.001947168,0.004433277],"category_scores_gemma":[0.002026622,0.0006929382,0.002106684,0.0004331471,0.0008990005,0.0008308422,0.0003820977,0.002825375,0.0005097526],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004752351,"about_ca_system_score_gemma":0.0006838581,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005549997,"about_ca_topic_score_gemma":0.001174836,"domain_scores_codex":[0.9991524,0.0004686044,0.00008272652,0.0001233944,0.00008856288,0.00008420769],"domain_scores_gemma":[0.998982,0.0003460714,0.0002548942,0.00007629394,0.00006065965,0.0002801142],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9788154,0.005825591,0.0006747583,0.0005680133,0.001182567,0.00003341175,0.00002283831,0.0001141367,0.001297334,0.00002312941,0.0002192403,0.0112236],"study_design_scores_gemma":[0.9510817,0.04525707,0.002097957,0.00003164063,0.0007258956,0.00002392803,0.000009741275,0.0002036462,0.0003399623,0.00002629211,0.0001943981,0.000007813163],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98984,0.005763136,0.0003866114,0.0003798528,0.0005546584,0.001518423,0.0004084632,0.00009333753,0.001055526],"genre_scores_gemma":[0.9902352,0.003890292,0.0009061033,0.0007845564,0.0007693542,0.001644548,0.0005047938,0.00001472048,0.001250586],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004433277,"threshold_uncertainty_score":0.01483077,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1658549429","doi":"10.1111/dom.12032","title":"Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre‐planned meta‐analysis of phase 3 trials","year":2012,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":350,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Insulin degludec; Insulin glargine; Medicine; Internal medicine; Insulin; Population; Diabetes mellitus; Hypoglycemia; Relative risk; Type 1 diabetes; Randomized controlled trial; Endocrinology; Confidence interval","authors":[{"name":"Robert E. Ratner","is_ca":false},{"name":"Stephanie Gough","is_ca":false},{"name":"Chantal Mathieu","is_ca":false},{"name":"Stefano Del Prato","is_ca":false},{"name":"Bruce W. Bode","is_ca":false},{"name":"Henriette Mersebach","is_ca":false},{"name":"Lars Endahl","is_ca":false},{"name":"Bernard Zinman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.102721218588195,"gpt":0.3644914413491033,"spread":0.2617702227609084,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01648105,0.003809813,0.01635214,0.002402892,0.0004772055,0.003735882,0.001672013,0.00249618,0.003953725],"category_scores_gemma":[0.02278338,0.0017089,0.06639024,0.003279008,0.0006696216,0.001610909,0.001357405,0.003260041,0.0003890813],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001727951,"about_ca_system_score_gemma":0.001172305,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004212871,"about_ca_topic_score_gemma":0.005006141,"domain_scores_codex":[0.9877923,0.007929975,0.00186928,0.001246138,0.000825815,0.0003365194],"domain_scores_gemma":[0.9858601,0.01028415,0.002210661,0.000783347,0.000601733,0.0002599781],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.01618253,0.00002862606,0.002554189,0.03254321,0.9439761,0.00006774601,0.00002867094,0.0005494767,0.0001902856,0.00006811209,0.0002962104,0.003514865],"study_design_scores_gemma":[0.004145263,0.0005354938,0.002683372,0.001496519,0.9900031,0.00005156155,0.00001851755,0.0003667157,0.000107399,0.0001385649,0.00043735,0.00001618433],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.05474716,0.9371836,0.002973751,0.000465107,0.000997394,0.0007964582,0.001429658,0.0001900474,0.001216834],"genre_scores_gemma":[0.778347,0.2091652,0.004792634,0.001609867,0.0006810056,0.0022083,0.001592822,0.0001584912,0.001444649],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01648105,"threshold_uncertainty_score":0.08716112,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2117505171","doi":"10.1111/dom.12187","title":"Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years","year":2013,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":295,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Astellas Pharma; AstraZeneca","keywords":"Dapagliflozin; Medicine; Placebo; Insulin; Adverse effect; Diabetes mellitus; Type 2 diabetes; Population; Internal medicine; Urology; Endocrinology","authors":[{"name":"John Wilding","is_ca":false},{"name":"Vincent Woo","is_ca":true},{"name":"Katja Rohwedder","is_ca":false},{"name":"Jennifer Sugg","is_ca":false},{"name":"Shamik Parikh","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.004339992995139996,"gpt":0.1913791158533762,"spread":0.1870391228582363,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001570651,0.0002368906,0.0009838655,0.0002229826,0.0001976451,0.0004711872,0.0001635837,0.000403064,0.0008662566],"category_scores_gemma":[0.001651524,0.0001652374,0.0004914738,0.0003017546,0.0001799708,0.0003572192,0.0001931526,0.0006158937,0.0001255741],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000276599,"about_ca_system_score_gemma":0.0002920228,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002863407,"about_ca_topic_score_gemma":0.0005538028,"domain_scores_codex":[0.999584,0.0001857885,0.00005234921,0.00006185721,0.00007600358,0.00004001663],"domain_scores_gemma":[0.9993216,0.000213663,0.000263311,0.00003370949,0.00004044529,0.000127237],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5208618,0.006905672,0.1908945,0.0009434929,0.001623798,0.0003444176,0.0001915409,0.0009491805,0.009044899,0.00008383045,0.001595366,0.2665616],"study_design_scores_gemma":[0.1346944,0.2525155,0.5962463,0.0002521048,0.002501631,0.001134285,0.0001824492,0.004335777,0.003565894,0.0002225228,0.004290944,0.00005830721],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931746,0.005751899,0.0002046382,0.000113847,0.00004484998,0.0001102716,0.0000980464,0.00001074227,0.0004909423],"genre_scores_gemma":[0.9973143,0.001626824,0.0003418145,0.0002009278,0.00009732122,0.0001108712,0.000141567,0.000001653386,0.0001646801],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001570651,"threshold_uncertainty_score":0.008306503,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2103828712","doi":"10.1111/j.1463-1326.2008.00994.x","title":"Fifty‐two‐week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy","year":2008,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":294,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"National Institute for Health and Care Research","keywords":"Vildagliptin; Glimepiride; Medicine; Metformin; Type 2 diabetes; Internal medicine; Diabetes mellitus; Type 2 Diabetes Mellitus; Hypoglycemia; Confidence interval; Randomized controlled trial; Gastroenterology; Endocrinology","authors":[{"name":"Eleuterio Ferrannini","is_ca":false},{"name":"Vivian Fonseca","is_ca":false},{"name":"Bernard Zinman","is_ca":true},{"name":"David R. Matthews","is_ca":false},{"name":"Bo Åhrén","is_ca":false},{"name":"S. Byiers","is_ca":false},{"name":"Qin Shao","is_ca":false},{"name":"S. Dejager","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009903568371051009,"gpt":0.2167715782832629,"spread":0.2068680099122119,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003000682,0.001120159,0.003498451,0.0003530495,0.0003599447,0.0008555888,0.0006634851,0.001296293,0.002616018],"category_scores_gemma":[0.003217189,0.0007632035,0.002424994,0.0002767963,0.0008066046,0.0009604329,0.0004601142,0.001980877,0.0004864731],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000579769,"about_ca_system_score_gemma":0.000561604,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002664893,"about_ca_topic_score_gemma":0.0004895145,"domain_scores_codex":[0.9984092,0.0008502775,0.0001815468,0.000275097,0.0001241872,0.0001597472],"domain_scores_gemma":[0.9979934,0.0006453724,0.0006219036,0.0002849396,0.00007343246,0.0003810824],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9637317,0.005992037,0.003055449,0.0002197877,0.0008190476,0.0000477008,0.00005775536,0.0004429847,0.008221407,0.00002021128,0.0001898816,0.01720201],"study_design_scores_gemma":[0.5639215,0.3979926,0.0320085,0.0000337339,0.001260063,0.00009105583,0.00003842197,0.001010639,0.002983913,0.00008381212,0.00052327,0.00005239415],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980217,0.0007657006,0.0002770525,0.00008452516,0.00006390658,0.0003069854,0.0001677851,0.0000339161,0.0002783812],"genre_scores_gemma":[0.9971256,0.0003650813,0.0006595601,0.0002224583,0.0001057445,0.0006294314,0.0003332311,0.00001165899,0.0005472075],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003498451,"threshold_uncertainty_score":0.01586926,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2785139619","doi":"10.1111/dom.13172","title":"Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":294,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novo Nordisk; Novo Nordisk Fonden; Steno Diabetes Center Copenhagen","keywords":"Medicine; Semaglutide; Glycated haemoglobin; Diabetic retinopathy; Glycated hemoglobin; Ophthalmology; Diabetes mellitus; Internal medicine; Type 2 diabetes; Endocrinology","authors":[{"name":"Tina Vilsbøll","is_ca":false},{"name":"Stephen C. Bain","is_ca":false},{"name":"Lawrence A. Leiter","is_ca":true},{"name":"Ildiko Lingvay","is_ca":false},{"name":"David Matthews","is_ca":false},{"name":"Rafael Simó","is_ca":false},{"name":"Ida Carøe Helmark","is_ca":false},{"name":"Nelun Wijayasinghe","is_ca":false},{"name":"Michael Larsen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007429259347866054,"gpt":0.2222728373629661,"spread":0.2148435780151,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005422783,0.0003356356,0.0008772953,0.0003864355,0.0001664936,0.0006623504,0.0006905026,0.001362711,0.00403424],"category_scores_gemma":[0.008889376,0.0001496592,0.001048635,0.0009463531,0.0002128285,0.000332384,0.000237357,0.0006636885,0.0005322785],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005583371,"about_ca_system_score_gemma":0.001346955,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003630502,"about_ca_topic_score_gemma":0.006575537,"domain_scores_codex":[0.9976809,0.001443882,0.0002070982,0.0001379037,0.0004566502,0.00007355819],"domain_scores_gemma":[0.9942406,0.002373698,0.001929047,0.0001803623,0.0008685009,0.0004076697],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2750387,0.002123278,0.1247059,0.01959364,0.008375933,0.0002638877,0.0003566813,0.001099536,0.00226978,0.00127557,0.08693153,0.4779656],"study_design_scores_gemma":[0.208841,0.07594514,0.602762,0.008360428,0.02307272,0.001320632,0.000291325,0.002906974,0.001950902,0.002875369,0.07153203,0.0001414799],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.530791,0.399747,0.0019092,0.02088323,0.0009203879,0.002027932,0.02189818,0.000456619,0.02136653],"genre_scores_gemma":[0.9107223,0.05835684,0.005017111,0.008647991,0.001043056,0.001993976,0.008540174,0.00007492839,0.00560362],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005422783,"threshold_uncertainty_score":0.02867877,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2045790951","doi":"10.1111/dom.12348","title":"Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease","year":2014,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":275,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"American Heart Association","keywords":"Canagliflozin; Medicine; Placebo; Internal medicine; Kidney disease; Renal function; Diabetes mellitus; Empagliflozin; Urology; Type 2 diabetes; Endocrinology; Gastroenterology; Pathology","authors":[{"name":"J.‐F. Yale","is_ca":true},{"name":"G. Bakris","is_ca":false},{"name":"Bertrand Cariou","is_ca":false},{"name":"Javier Nieto Guevara","is_ca":false},{"name":"Elias David‐Neto","is_ca":false},{"name":"Dennis K. Yue","is_ca":false},{"name":"Ewa Wajs","is_ca":false},{"name":"K. Figueroa","is_ca":false},{"name":"Joel Jiang","is_ca":false},{"name":"Ga‐Lai Law","is_ca":false},{"name":"Keith Usiskin","is_ca":false},{"name":"Gary Meininger","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.003466919050973172,"gpt":0.1939832019677004,"spread":0.1905162829167272,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001361482,0.0004682044,0.001715282,0.0002836948,0.0002021896,0.0004304246,0.0003009984,0.0005896113,0.001390062],"category_scores_gemma":[0.001083167,0.0002254488,0.0007457181,0.0003623166,0.0002648224,0.0004333048,0.0002238324,0.001028076,0.0002032816],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003191598,"about_ca_system_score_gemma":0.0003817098,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000510997,"about_ca_topic_score_gemma":0.0009495314,"domain_scores_codex":[0.9995375,0.0001639947,0.00005167463,0.00009782751,0.00008741347,0.00006155387],"domain_scores_gemma":[0.9995322,0.0001305677,0.0001541594,0.00003182077,0.00003240753,0.0001188193],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.724295,0.02160432,0.03666256,0.001095366,0.002438868,0.0001814648,0.0001400449,0.001754439,0.01908274,0.00004667586,0.001018193,0.1916804],"study_design_scores_gemma":[0.3228944,0.4402384,0.2207971,0.0001295376,0.002395889,0.0006098517,0.0001136743,0.003636845,0.006267719,0.0001226672,0.002734355,0.00005943215],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948547,0.003944139,0.0002079741,0.0001067643,0.00004556878,0.0001756445,0.0001119226,0.00002485687,0.0005284348],"genre_scores_gemma":[0.9967771,0.001420172,0.0004756874,0.0002972074,0.0001170379,0.0001922052,0.0002459318,0.000004358848,0.0004703502],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001715282,"threshold_uncertainty_score":0.007200301,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2388825372","doi":"10.1111/dom.12689","title":"Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global <scp>HAT</scp> study","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":274,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Science and Engineering Research Board; Novo Nordisk; National Institute for Health and Care Research; Boehringer Ingelheim; Medtronic; Sanofi; Medpace; GlaxoSmithKline; Bristol-Myers Squibb; AstraZeneca; Takeda Pharmaceuticals U.S.A.; Pfizer","keywords":"Medicine; Insulin; Type 2 diabetes; Type 1 diabetes; Internal medicine; Diabetes mellitus; Endocrinology","authors":[{"name":"Kamlesh Khunti","is_ca":false},{"name":"Saud Alsifri","is_ca":false},{"name":"Ronnie Aronson","is_ca":true},{"name":"Maja Cigrovski Berković","is_ca":false},{"name":"Catherine F. Enters-Weijnen","is_ca":false},{"name":"Tom Forsén","is_ca":false},{"name":"G. R. Galstyan","is_ca":false},{"name":"Petronella Geelhoed-Duijvestijn","is_ca":false},{"name":"Margalit Goldfracht","is_ca":false},{"name":"Helge Gydesen","is_ca":false},{"name":"Rahul Kapur","is_ca":false},{"name":"Nebojša Lalić","is_ca":false},{"name":"Bernhard Ludvik","is_ca":false},{"name":"Erik Moberg","is_ca":false},{"name":"Ulrik Pedersen‐Bjergaard","is_ca":false},{"name":"Ambady Ramachandran","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009119883461574484,"gpt":0.2351211298809587,"spread":0.2260012464193842,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001060864,0.0005478567,0.0005754985,0.0008646486,0.0003463287,0.0008438826,0.0004558696,0.0006589047,0.0008203775],"category_scores_gemma":[0.001843181,0.0006574096,0.0008625927,0.001549923,0.0003128001,0.0006043299,0.0007374644,0.0006863821,0.0002250927],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003026512,"about_ca_system_score_gemma":0.0002388731,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009975367,"about_ca_topic_score_gemma":0.007656076,"domain_scores_codex":[0.9992725,0.0002647458,0.0000988602,0.0001687267,0.0001078654,0.00008738646],"domain_scores_gemma":[0.9979509,0.0003083788,0.001162614,0.0001306009,0.0001735678,0.0002739737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00009560949,0.00002385493,0.9991955,0.00001172116,0.00006536292,0.00003024209,0.0000753167,0.00002834911,0.00003215391,0.000002794853,0.00007486626,0.0003642619],"study_design_scores_gemma":[0.00002190685,0.0001393803,0.9991623,0.00000790901,0.00003833032,0.0001228974,0.0002674937,0.0001071936,0.00002214037,0.000005004093,0.0001004603,0.000004992843],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982948,0.0002730096,0.00004911962,0.00002048087,0.00000704658,0.00001166997,0.001114427,0.000003163521,0.0002263324],"genre_scores_gemma":[0.9981971,0.0002123948,0.000065661,0.00002644227,0.00001018531,0.00002182463,0.001344973,0.00000242928,0.0001189337],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009975367,"threshold_uncertainty_score":0.01983464,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1987329229","doi":"10.1111/j.1463-1326.2012.01564.x","title":"Acute high‐intensity interval exercise reduces the postprandial glucose response and prevalence of hyperglycaemia in patients with type 2 diabetes","year":2012,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Cardiovascular and exercise physiology","field":"Medicine","cited_by":274,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"York University; McMaster University","funders":"Canadian Diabetes Association","keywords":"Postprandial; Medicine; Type 2 diabetes; Internal medicine; Diabetes mellitus; Cardiology; Meal; Endocrinology; Heart rate; Blood pressure","authors":[{"name":"Jenna B. Gillen","is_ca":true},{"name":"Jonathan P. Little","is_ca":true},{"name":"Zubin Punthakee","is_ca":true},{"name":"Mark A. Tarnopolsky","is_ca":true},{"name":"Michael C. Riddell","is_ca":true},{"name":"Martin J. Gibala","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005067005503531495,"gpt":0.1985326668314524,"spread":0.1934656613279209,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000505651,0.00030813,0.0007671732,0.0002895971,0.0003998913,0.0004086623,0.0003147637,0.002199464,0.001599005],"category_scores_gemma":[0.003332592,0.0001241458,0.000238481,0.000334674,0.0002542187,0.0003067612,0.0001432574,0.001158232,0.0008215624],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000370882,"about_ca_system_score_gemma":0.000245843,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001010501,"about_ca_topic_score_gemma":0.00217927,"domain_scores_codex":[0.999709,0.0001047274,0.00004078045,0.00003098726,0.00008117466,0.00003335826],"domain_scores_gemma":[0.9991247,0.0004555955,0.00007825401,0.00003875927,0.0001879402,0.0001147202],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.01123926,0.002506841,0.2788364,0.0006655517,0.000220673,0.03715013,0.00051179,0.0003856501,0.009136086,0.0007824452,0.184104,0.4744613],"study_design_scores_gemma":[0.002723696,0.01077024,0.7941635,0.0007292784,0.0004165639,0.071411,0.001015835,0.004535494,0.00399962,0.003733188,0.1063959,0.000105709],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6713261,0.03264556,0.002425384,0.2455215,0.008876483,0.0002521758,0.0005944211,0.0003521879,0.03800607],"genre_scores_gemma":[0.8530524,0.01190881,0.002339081,0.1050899,0.01504897,0.0002183549,0.0003547888,0.00005214096,0.01193543],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002199464,"threshold_uncertainty_score":0.005349219,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2791162071","doi":"10.1111/dom.13301","title":"Effects of the SGLT‐2 inhibitor dapagliflozin on glomerular and tubular injury markers","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; Diabetes Canada; University of Toronto","funders":"Banting and Best Diabetes Centre, University of Toronto; Canadian Institutes of Health Research; University of Toronto; Nederlandse Organisatie voor Wetenschappelijk Onderzoek","keywords":"Dapagliflozin; Albuminuria; Urology; Medicine; Internal medicine; Excretion; Endocrinology; Urinary system; Placebo; Renal function; Diabetes mellitus; Type 2 diabetes; Pathology","authors":[{"name":"Claire C. J. Dekkers","is_ca":false},{"name":"S. Petrykiv","is_ca":false},{"name":"Gozewijn D. Laverman","is_ca":false},{"name":"David Z.I. Cherney","is_ca":true},{"name":"Ron T. Gansevoort","is_ca":false},{"name":"Hiddo J.L. Heerspink","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.003217106928791652,"gpt":0.2010172284188842,"spread":0.1978001214900925,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00150722,0.0005227181,0.001804755,0.0001796752,0.00009406522,0.0004398482,0.0001918556,0.000346072,0.0008093629],"category_scores_gemma":[0.001040651,0.0002035278,0.001069095,0.0001442827,0.0003160796,0.0003920069,0.0002066483,0.00104692,0.00007237219],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002590303,"about_ca_system_score_gemma":0.000352271,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003974011,"about_ca_topic_score_gemma":0.000962622,"domain_scores_codex":[0.9996067,0.0001967408,0.00003921839,0.00005121544,0.00004762736,0.00005855684],"domain_scores_gemma":[0.9991664,0.0004339418,0.0001363046,0.00006581344,0.00004658285,0.0001510729],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.7843886,0.008868451,0.01141773,0.001101562,0.003751373,0.0001021326,0.0001094947,0.00278568,0.1015355,0.0001254359,0.0005711657,0.08524282],"study_design_scores_gemma":[0.07683636,0.6572585,0.1496184,0.00009938767,0.008342093,0.0001807208,0.00008673626,0.007713501,0.09656128,0.0002673615,0.002979873,0.00005585419],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974505,0.001728321,0.0003037241,0.00006417358,0.00005413355,0.00007069225,0.00008219668,0.0000166718,0.0002295133],"genre_scores_gemma":[0.9978499,0.0006371419,0.0006358117,0.0001077619,0.00007249127,0.0001054142,0.0001195523,0.000005547325,0.0004663938],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001804755,"threshold_uncertainty_score":0.007971048,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3106995227","doi":"10.1111/dom.14269","title":"Proportion of newly diagnosed diabetes in <scp>COVID</scp> ‐19 patients: A systematic review and meta‐analysis","year":2020,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":256,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Meta-analysis; Diabetes mellitus; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Medicine; Internal medicine; Virology; Disease; Endocrinology; Infectious disease (medical specialty)","authors":[{"name":"Thirunavukkarasu Sathish","is_ca":true},{"name":"Nitin Kapoor","is_ca":false},{"name":"Yingting Cao","is_ca":false},{"name":"Robyn J. Tapp","is_ca":false},{"name":"Paul Zimmet","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05036164860493033,"gpt":0.3729185743708902,"spread":0.3225569257659598,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009960615,0.001216618,0.007638674,0.003945677,0.0003893759,0.001650571,0.001004018,0.001021101,0.004711549],"category_scores_gemma":[0.02483451,0.0008182107,0.01554659,0.006622218,0.0002939667,0.001086193,0.0009919896,0.001159513,0.0003552448],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00149624,"about_ca_system_score_gemma":0.00238624,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005700375,"about_ca_topic_score_gemma":0.01493212,"domain_scores_codex":[0.9941823,0.002526298,0.001679461,0.0006853997,0.0007293301,0.000197159],"domain_scores_gemma":[0.9850984,0.011466,0.001656806,0.0004345176,0.001185278,0.0001589916],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.003538962,0.00003615615,0.01899373,0.5659645,0.3636091,0.0001873799,0.0001282059,0.0004153603,0.0003518357,0.0003262155,0.00711211,0.03933652],"study_design_scores_gemma":[0.001109379,0.000305262,0.0304798,0.08053203,0.8747491,0.0002842312,0.0001183263,0.0003782227,0.0002709542,0.0004527005,0.01126687,0.00005310754],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004885126,0.9918267,0.0003644179,0.0002974216,0.000168872,0.0001566633,0.001990874,0.00001680437,0.0002931779],"genre_scores_gemma":[0.1275082,0.8649443,0.001912939,0.0006932975,0.0003023761,0.001088923,0.002964244,0.00003119508,0.0005545563],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009960615,"threshold_uncertainty_score":0.05267745,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1982905493","doi":"10.1111/dom.12273","title":"Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone","year":2014,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":253,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Canagliflozin; Metformin; Sitagliptin; Medicine; Placebo; Pioglitazone; Internal medicine; Type 2 diabetes; Endocrinology; Adverse effect; Urology; Diabetes mellitus; Gastroenterology; Pharmacology","authors":[{"name":"Thomas Först","is_ca":false},{"name":"Robert Guthrie","is_ca":false},{"name":"Ronald Goldenberg","is_ca":true},{"name":"Jacqueline Yee","is_ca":false},{"name":"Ujjwala Vijapurkar","is_ca":false},{"name":"Gary Meininger","is_ca":false},{"name":"Peter Stein","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005842506116560182,"gpt":0.2062542905764193,"spread":0.2004117844598591,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001318289,0.000572426,0.001536892,0.000311122,0.0002923493,0.0005379974,0.0003427697,0.0007107574,0.001344745],"category_scores_gemma":[0.001530238,0.0003536503,0.000909513,0.0003711501,0.0002924878,0.0005345226,0.0002311174,0.001159616,0.0002308397],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004124742,"about_ca_system_score_gemma":0.0004874868,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006458102,"about_ca_topic_score_gemma":0.001278071,"domain_scores_codex":[0.9995383,0.0001651988,0.00004421719,0.0001052587,0.00008683358,0.00006016508],"domain_scores_gemma":[0.9992635,0.0001795262,0.0002332991,0.00006286296,0.00004244783,0.000218497],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8050942,0.01416244,0.04274995,0.0004725426,0.00176329,0.0001744065,0.0001699257,0.00108943,0.01073927,0.00004892148,0.0008874352,0.1226482],"study_design_scores_gemma":[0.4007714,0.2955121,0.2918471,0.00009615142,0.002358564,0.0004420081,0.0001329794,0.00321598,0.003684652,0.0001657521,0.001705329,0.00006787923],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972402,0.001786481,0.0001198765,0.0001050132,0.00003319104,0.0001192871,0.00009341491,0.00002210815,0.0004805668],"genre_scores_gemma":[0.9980312,0.0006742465,0.0003217627,0.000219582,0.00006320971,0.0001350035,0.0002166226,0.000004182106,0.0003341788],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001536892,"threshold_uncertainty_score":0.006971896,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2106144638","doi":"10.1111/j.1463-1326.2009.01057.x","title":"Home telehealth for diabetes management: a systematic review and meta‐analysis","year":2009,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":246,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Telehealth; Medicine; MEDLINE; Telemedicine; Randomized controlled trial; Confidence interval; Meta-analysis; Health care; Quality of life (healthcare); Telecare; Diabetes mellitus; Family medicine; Population; Physical therapy; Nursing; Internal medicine","authors":[{"name":"Julie Polisena","is_ca":true},{"name":"Khai Tran","is_ca":true},{"name":"Karen Cimon","is_ca":true},{"name":"Brian Hutton","is_ca":true},{"name":"Sarah McGill","is_ca":true},{"name":"Krisan Palmer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0449793117447659,"gpt":0.3552800111706239,"spread":0.310300699425858,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01073918,0.001977606,0.01536671,0.005153153,0.0005473499,0.002298519,0.00203767,0.001990668,0.004472144],"category_scores_gemma":[0.02759388,0.00102566,0.02509912,0.006666796,0.0005856055,0.001390232,0.0009901159,0.001721247,0.0002420929],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002480782,"about_ca_system_score_gemma":0.003192465,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006919831,"about_ca_topic_score_gemma":0.01254496,"domain_scores_codex":[0.993244,0.003818567,0.001423803,0.0005600886,0.0007631179,0.0001904859],"domain_scores_gemma":[0.9818823,0.01429779,0.002353393,0.0003496561,0.0008969692,0.0002199224],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002900812,0.00008874325,0.002941258,0.4748153,0.4908161,0.0001479345,0.000085737,0.0005899714,0.0001430231,0.0001273948,0.0009304404,0.02641337],"study_design_scores_gemma":[0.001747987,0.0005615973,0.004437033,0.05265447,0.9378771,0.0001451576,0.00006408776,0.0003148769,0.0001356869,0.0001931442,0.00184147,0.00002737422],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003437579,0.9952204,0.0003498474,0.0001720485,0.0001024712,0.0002636826,0.0002434817,0.00001690993,0.0001934755],"genre_scores_gemma":[0.114849,0.880685,0.001846368,0.0006309244,0.0002331581,0.001119846,0.0004054453,0.00001585846,0.0002143319],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01536671,"threshold_uncertainty_score":0.05679488,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2031730303","doi":"10.1111/dom.12428","title":"Long‐term efficacy and safety of canagliflozin over 104 weeks in patients aged 55–80 years with type 2 diabetes","year":2014,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Janssen Research and Development; American Heart Association","keywords":"Canagliflozin; Medicine; Placebo; Blood pressure; Internal medicine; Type 2 diabetes; Endocrinology; Diabetes mellitus; Regimen; Adverse effect; Gastroenterology","authors":[{"name":"Bruce W. Bode","is_ca":false},{"name":"Kaj Stenlöf","is_ca":false},{"name":"Stewart B. Harris","is_ca":true},{"name":"Daniel J. Sullivan","is_ca":false},{"name":"Albert Fung","is_ca":false},{"name":"Keith Usiskin","is_ca":false},{"name":"Gary Meininger","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.004615864103886198,"gpt":0.2017139409233324,"spread":0.1970980768194462,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001179826,0.0004331698,0.001403133,0.0003183724,0.0003347423,0.0004469199,0.0002711494,0.0005719305,0.0008805388],"category_scores_gemma":[0.001093597,0.0002737462,0.0008559724,0.0003815161,0.0002683756,0.0004575821,0.0002424923,0.0008918457,0.0001602351],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003325827,"about_ca_system_score_gemma":0.0003769576,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009534127,"about_ca_topic_score_gemma":0.001843082,"domain_scores_codex":[0.9997023,0.0000917407,0.00003313253,0.0000566617,0.00006221165,0.00005400441],"domain_scores_gemma":[0.9994923,0.00009521806,0.0001667318,0.00002866577,0.00003823135,0.0001788645],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5847967,0.02585903,0.1795521,0.0008111307,0.003690859,0.0003820203,0.000286834,0.001990974,0.01571288,0.0000513681,0.001405931,0.1854603],"study_design_scores_gemma":[0.1548646,0.2779394,0.556524,0.0001211162,0.003206868,0.0005586501,0.0001541416,0.002140478,0.002462756,0.00008721924,0.001879627,0.00006114948],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974654,0.001891544,0.00008479614,0.00006115097,0.00002614246,0.00006681532,0.00006144548,0.00001161478,0.0003309885],"genre_scores_gemma":[0.9980096,0.0009583175,0.0002000273,0.0002089813,0.0000746127,0.00009077798,0.0001933474,0.00000199625,0.0002624312],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001403133,"threshold_uncertainty_score":0.006239593,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2998275298","doi":"10.1111/dom.13955","title":"Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ted Rogers Centre for Heart Research; Toronto General Hospital","funders":"Novo Nordisk; Steno Diabetes Center Copenhagen","keywords":"Semaglutide; Medicine; Type 2 diabetes; Diabetes mellitus; Internal medicine; Cardiology; Intensive care medicine; Endocrinology; Liraglutide","authors":[{"name":"Mansoor Husain","is_ca":true},{"name":"Stephen C. Bain","is_ca":false},{"name":"Ole Kleist Jeppesen","is_ca":false},{"name":"Ildiko Lingvay","is_ca":false},{"name":"Rasmus Sørrig","is_ca":false},{"name":"Marianne Bach Treppendahl","is_ca":false},{"name":"Tina Vilsbøll","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01189550944405662,"gpt":0.2250810476526189,"spread":0.2131855382085622,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001955923,0.000453869,0.001384611,0.0003258553,0.0001233,0.0005226105,0.0002838855,0.0005037553,0.001256616],"category_scores_gemma":[0.001641027,0.0001704382,0.001111609,0.0003822908,0.0002715947,0.0005002687,0.0002594478,0.0007495946,0.0001197689],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002193864,"about_ca_system_score_gemma":0.0002932741,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000473371,"about_ca_topic_score_gemma":0.001851891,"domain_scores_codex":[0.9995815,0.000201828,0.00004275415,0.00006415288,0.00007226784,0.0000375727],"domain_scores_gemma":[0.9992877,0.0002663329,0.0002404062,0.00004525713,0.00004684013,0.0001135704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.658733,0.004581406,0.0378476,0.004262548,0.01244277,0.000206605,0.0001294785,0.002329196,0.01502541,0.0003531574,0.00210388,0.261985],"study_design_scores_gemma":[0.2899744,0.3259462,0.3495228,0.0006375238,0.01559004,0.00110009,0.0001934683,0.004138276,0.006507981,0.001129575,0.005154379,0.0001053101],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9739733,0.02342855,0.0003046113,0.0002366189,0.00006989967,0.0001308481,0.0004215968,0.00004863031,0.001386002],"genre_scores_gemma":[0.991316,0.006268745,0.0008597781,0.0003613093,0.0001557234,0.00009280278,0.0005750511,0.000005772335,0.0003648334],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001955923,"threshold_uncertainty_score":0.01034403,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2107562831","doi":"10.1111/j.1463-1326.2010.01233.x","title":"Vildagliptin add‐on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2‐year study","year":2010,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"National Institute for Health and Care Research","keywords":"Vildagliptin; Glimepiride; Medicine; Metformin; Diabetes mellitus; Internal medicine; Type 2 diabetes; Gastroenterology; Endocrinology","authors":[{"name":"David R. Matthews","is_ca":false},{"name":"S. Dejager","is_ca":false},{"name":"Bo Åhrén","is_ca":false},{"name":"Vivian Fonseca","is_ca":false},{"name":"Eleuterio Ferrannini","is_ca":false},{"name":"A. Couturier","is_ca":false},{"name":"James E. Foley","is_ca":false},{"name":"Bernard Zinman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008943048231581338,"gpt":0.2239946282967743,"spread":0.215051580065193,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005141865,0.001501154,0.003850427,0.000652628,0.0003567567,0.001323844,0.001139581,0.002136434,0.003577086],"category_scores_gemma":[0.003075832,0.0008819137,0.003466115,0.0005124852,0.001464233,0.001507948,0.0004076425,0.00269024,0.000663647],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008165914,"about_ca_system_score_gemma":0.0006985791,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005148401,"about_ca_topic_score_gemma":0.0008090456,"domain_scores_codex":[0.9975734,0.001382886,0.0002251252,0.0003329518,0.0002538289,0.000231833],"domain_scores_gemma":[0.9970012,0.0009428498,0.0009061576,0.0004596194,0.0001475277,0.0005426251],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9559749,0.01647741,0.001257562,0.0004479316,0.001673046,0.00007876077,0.00005315085,0.0001688745,0.007723633,0.00003341741,0.0002164466,0.01589483],"study_design_scores_gemma":[0.5427577,0.4417086,0.01111614,0.0000410098,0.001707842,0.0001211819,0.00003147405,0.0003272118,0.001624241,0.00006120958,0.000469531,0.00003384075],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957819,0.002809542,0.0002177675,0.0001166664,0.0001509195,0.0003117915,0.0002170242,0.00003065959,0.0003637624],"genre_scores_gemma":[0.994769,0.001996172,0.0005937966,0.0003778106,0.0004993668,0.0003019653,0.0005586875,0.00001698466,0.0008861408],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005141865,"threshold_uncertainty_score":0.02719313,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2807732548","doi":"10.1111/dom.13413","title":"Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"National Institutes of Health; National Center for Advancing Translational Sciences; AstraZeneca","keywords":"Dapagliflozin; Medicine; Placebo; Renal function; Kidney disease; Type 2 diabetes; Internal medicine; Urology; Clinical endpoint; Adverse effect; Randomization; Diabetes mellitus; Gastroenterology; Randomized controlled trial; Endocrinology","authors":[{"name":"Paola Fioretto","is_ca":false},{"name":"Stefano Del Prato","is_ca":false},{"name":"John B. Buse","is_ca":false},{"name":"Ronald Goldenberg","is_ca":true},{"name":"Francesco Giorgino","is_ca":false},{"name":"Daniel Reyner","is_ca":false},{"name":"Anna Maria Langkilde","is_ca":false},{"name":"C. David Sjöström","is_ca":false},{"name":"Peter Sartipy","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005970261016607593,"gpt":0.2181164105582141,"spread":0.2121461495416065,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002183169,0.0006190629,0.002428496,0.0002193322,0.0002206535,0.0006932476,0.0004090669,0.0007242917,0.002245638],"category_scores_gemma":[0.002895137,0.0002640875,0.001795297,0.0003182316,0.0003579757,0.0004929462,0.0005249602,0.001251735,0.0003819451],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003394037,"about_ca_system_score_gemma":0.0004274289,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003197159,"about_ca_topic_score_gemma":0.000795996,"domain_scores_codex":[0.9990722,0.0005479401,0.00005492211,0.0001071907,0.0001655377,0.00005214287],"domain_scores_gemma":[0.9991258,0.0003189442,0.0002343363,0.00008657661,0.00007852029,0.0001559931],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8336923,0.01030081,0.03863831,0.001203765,0.007190348,0.0001442568,0.0001306906,0.001606135,0.006567184,0.0003586544,0.00411777,0.09604982],"study_design_scores_gemma":[0.6305483,0.168537,0.172883,0.0002345349,0.009899941,0.000544171,0.00009626914,0.005126485,0.002842228,0.0007349452,0.008443979,0.0001090727],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98602,0.008276371,0.0004974082,0.000492193,0.00009789775,0.0004396692,0.001379456,0.00003516922,0.002761715],"genre_scores_gemma":[0.993763,0.002403772,0.0005185799,0.0006977976,0.0002766949,0.0003148164,0.001166998,0.000009713067,0.0008485804],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002428496,"threshold_uncertainty_score":0.01154584,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2621101635","doi":"10.1111/dom.13028","title":"Design and baseline characteristics of participants in the <scp>R</scp> esearching cardiovascular <scp>E</scp> vents with a <scp>W</scp> eekly <scp>IN</scp> cretin in <scp>D</scp> iabetes ( <scp>REWIND</scp> ) trial on the cardiovascular effects of dulaglutide","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; Population Health Research Institute; Université Laval; University of Toronto; Hamilton Health Sciences; McMaster University","funders":"Regeneron Pharmaceuticals; Novo Nordisk; Sanofi; Servier; Amgen; Pfizer; AstraZeneca; Duke Clinical Research Institute; Eli Lilly and Company; Mylan; GlaxoSmithKline","keywords":"Medicine","authors":[{"name":"Hertzel C. Gerstein","is_ca":true},{"name":"Helen M. Colhoun","is_ca":false},{"name":"Gilles R. Dagenais","is_ca":true},{"name":"Rafael Díaz","is_ca":false},{"name":"Mark Lakshmanan","is_ca":false},{"name":"Prem Pais","is_ca":false},{"name":"Jeffrey L. Probstfield","is_ca":false},{"name":"Matthew C. Riddle","is_ca":false},{"name":"Lars Rydén","is_ca":false},{"name":"Denis Xavier","is_ca":false},{"name":"Charles Atisso","is_ca":false},{"name":"Álvaro Avezum","is_ca":false},{"name":"Jan Basile","is_ca":false},{"name":"Namsik Chung","is_ca":false},{"name":"Ignacio Conget","is_ca":false},{"name":"William C. Cushman","is_ca":false},{"name":"Edward Franek","is_ca":false},{"name":"Nicolae Hâncu","is_ca":false},{"name":"M Hanefeld","is_ca":false},{"name":"Shaun Holt","is_ca":false},{"name":"Petr Janský","is_ca":false},{"name":"Mátyás Keltai","is_ca":false},{"name":"Fernando Laņas","is_ca":false},{"name":"Lawrence A. Leiter","is_ca":true},{"name":"Patricio López‐Jaramillo","is_ca":false},{"name":"Ernesto Germán Cardona-Muñóz","is_ca":false},{"name":"Valdis Pīrāgs","is_ca":false},{"name":"Nana Pogosova","is_ca":false},{"name":"Peter Raubenheimer","is_ca":false},{"name":"Jonathan E. Shaw","is_ca":false},{"name":"Wayne Huey‐Herng Sheu","is_ca":false},{"name":"Theodora Temelkova‐Kurktschiev","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02342545171499733,"gpt":0.2439605460816667,"spread":0.2205350943666694,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004897096,0.001832989,0.002199319,0.0009855734,0.001416393,0.0009507209,0.001243331,0.002067323,0.01591885],"category_scores_gemma":[0.004855662,0.001186157,0.001307036,0.001266312,0.001062451,0.001164608,0.0007562652,0.002114482,0.003792558],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00124129,"about_ca_system_score_gemma":0.003020876,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003413403,"about_ca_topic_score_gemma":0.003807016,"domain_scores_codex":[0.9961022,0.001309325,0.0003623666,0.001033545,0.0005044128,0.0006880567],"domain_scores_gemma":[0.9986274,0.0002413586,0.0002654208,0.0001458255,0.0003105301,0.0004094285],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5082614,0.07701892,0.2816421,0.003310568,0.002740756,0.001602091,0.003212033,0.001375759,0.00859545,0.003215083,0.0171742,0.09185155],"study_design_scores_gemma":[0.1901079,0.2683403,0.4679346,0.001046747,0.002466538,0.001509808,0.003096781,0.003084623,0.002284177,0.009940028,0.04966316,0.0005252086],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7924514,0.006738875,0.01015264,0.00149771,0.0006557152,0.1459294,0.02766898,0.0001125539,0.01479274],"genre_scores_gemma":[0.6730001,0.001319972,0.01111737,0.004398989,0.0003148245,0.2872905,0.009873153,0.00005892339,0.01262628],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01591885,"threshold_uncertainty_score":0.05325389,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2155334088","doi":"10.1111/j.1463-1326.2011.01450.x","title":"Regulation of glucagon secretion by glucose: paracrine, intrinsic or both?","year":2011,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"National Institutes of Health; Medical Research Council; National Institute for Health and Care Research; Canada Research Chairs; Wellcome Trust","keywords":"Paracrine signalling; Glucagon; Secretion; Internal medicine; Endocrinology; Depolarization; Islet; Somatostatin; Blood sugar regulation; Biology; Cell biology; Chemistry; Insulin; Receptor; Medicine","authors":[{"name":"Jonathan N. Walker","is_ca":false},{"name":"Reshma Ramracheya","is_ca":false},{"name":"Quan Zhang","is_ca":true},{"name":"Paul Johnson","is_ca":false},{"name":"M. Braun","is_ca":true},{"name":"Patrik Rorsman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0281236078666534,"gpt":0.2748657014297744,"spread":0.246742093563121,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006395064,0.0008548798,0.001818095,0.0009710805,0.0002276217,0.001006455,0.0008860801,0.001060901,0.001873047],"category_scores_gemma":[0.0005850641,0.0002129205,0.0003283691,0.001421534,0.0009292517,0.00236645,0.0005295537,0.001517779,0.00144109],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005935277,"about_ca_system_score_gemma":0.0007016654,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004433966,"about_ca_topic_score_gemma":0.0007022133,"domain_scores_codex":[0.9998362,0.00003472512,0.00002586561,0.00003030114,0.00005400046,0.00001884292],"domain_scores_gemma":[0.9997825,0.00009962226,0.000033376,0.00001054694,0.00004730647,0.0000266102],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001079279,0.00005430664,0.0004950963,0.01407513,0.0001105154,0.0005536655,0.0001331642,0.0002377413,0.004019323,0.008291636,0.01967497,0.9522465],"study_design_scores_gemma":[0.0000324317,0.0001588122,0.001918221,0.003983343,0.0001523393,0.004281542,0.0002732569,0.0001109247,0.001353941,0.006251252,0.9814489,0.00003489519],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001214124,0.9987207,0.000141619,0.0003236043,0.0002033756,0.000001400335,0.000005924639,0.000004642947,0.0004772344],"genre_scores_gemma":[0.0007280359,0.9983824,0.0001283133,0.0001916732,0.0002517909,0.000003123715,0.000007762425,8.856951e-7,0.0003060246],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001873047,"threshold_uncertainty_score":0.006265938,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2895653157","doi":"10.1111/dom.13550","title":"Association between diabetic eye disease and other complications of diabetes: Implications for care. A systematic review","year":2018,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Bayer","keywords":"Medicine; Diabetes mellitus; Macrovascular disease; Diabetic retinopathy; Referral; Disease; Stroke (engine); Nephropathy; Intensive care medicine; Retinopathy; Type 2 diabetes; Internal medicine; Family medicine","authors":[{"name":"Ian Pearce","is_ca":false},{"name":"Rafael Simó","is_ca":false},{"name":"Monica Lövestam‐Adrian","is_ca":false},{"name":"David T. Wong","is_ca":true},{"name":"Marc Evans","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03245947634275809,"gpt":0.3370501022343341,"spread":0.304590625891576,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009325206,0.001211374,0.007337052,0.009757689,0.0005601122,0.002687332,0.001572363,0.001894408,0.004784856],"category_scores_gemma":[0.05568133,0.001175704,0.009019806,0.01154845,0.0007452161,0.00220729,0.001351161,0.00145841,0.0002938711],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003497298,"about_ca_system_score_gemma":0.01246893,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01762518,"about_ca_topic_score_gemma":0.04829999,"domain_scores_codex":[0.9909146,0.003193733,0.003564388,0.0006414591,0.001395805,0.0002900939],"domain_scores_gemma":[0.9541415,0.03429273,0.007814853,0.0005765804,0.002807893,0.0003663895],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001130838,0.00001066325,0.001739822,0.9579395,0.01179556,0.00007767526,0.0001078453,0.00009007182,0.0000618888,0.0002081545,0.002500288,0.02535544],"study_design_scores_gemma":[0.0002299624,0.00011621,0.007541591,0.8847709,0.08973969,0.0003634308,0.0002201548,0.00009956381,0.00007493442,0.0004479276,0.01636131,0.00003433883],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000467435,0.9983009,0.00007275998,0.0003642691,0.0001186572,0.0001079579,0.0004137906,0.000004230074,0.0001501857],"genre_scores_gemma":[0.01322141,0.9846332,0.000463049,0.0008909843,0.000120075,0.0002823778,0.0002983056,0.000005358539,0.00008523768],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01762518,"threshold_uncertainty_score":0.049317,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2099670937","doi":"10.1111/dom.12494","title":"Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4‐week, randomized, placebo‐controlled trial ( <scp>EASE</scp> ‐1)","year":2015,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Eli Lilly and Company; Boehringer Ingelheim","keywords":"Empagliflozin; Placebo; Medicine; Insulin; Type 2 diabetes; Clinical endpoint; Internal medicine; Diabetes mellitus; Randomized controlled trial; Adverse effect; Endocrinology","authors":[{"name":"Thomas R. Pieber","is_ca":false},{"name":"Susanne Famulla","is_ca":false},{"name":"Jens Eilbracht","is_ca":false},{"name":"Jessica Cescutti","is_ca":false},{"name":"Nima Soleymanlou","is_ca":true},{"name":"Odd Erik Johansen","is_ca":false},{"name":"Hans J. Woerle","is_ca":false},{"name":"Uli C. Broedl","is_ca":false},{"name":"Stefan Kaspers","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01363860986802511,"gpt":0.2461924121162025,"spread":0.2325538022481774,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001483549,0.001441956,0.003304479,0.0004545379,0.0003423714,0.000965547,0.0008315409,0.001769151,0.006337528],"category_scores_gemma":[0.001379188,0.0006630977,0.001593804,0.0004625052,0.0008910763,0.0008270228,0.0003610933,0.002550873,0.0007469783],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004999978,"about_ca_system_score_gemma":0.0009130783,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007396963,"about_ca_topic_score_gemma":0.001710023,"domain_scores_codex":[0.999485,0.0002459972,0.00004473401,0.0001083694,0.00004801388,0.00006790966],"domain_scores_gemma":[0.9993423,0.0001829924,0.000189638,0.00005015413,0.00004277087,0.0001921964],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9827417,0.004129183,0.0003592005,0.0004885594,0.0005566332,0.0000196861,0.0000156899,0.0001264246,0.001604284,0.00002301009,0.0002709583,0.009664709],"study_design_scores_gemma":[0.9714115,0.02686447,0.001066212,0.00001718727,0.0002016279,0.00001219261,0.000004483722,0.0001260097,0.0001438682,0.00001476229,0.0001328519,0.000004968692],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9872583,0.005940951,0.0005550554,0.0005476896,0.0006918894,0.002917792,0.0006684768,0.0001268971,0.001293119],"genre_scores_gemma":[0.9819629,0.00508596,0.001951415,0.001265346,0.001062663,0.004869548,0.001066671,0.00002076654,0.002714547],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006337528,"threshold_uncertainty_score":0.02120113,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2600127085","doi":"10.1111/dom.12958","title":"Treatment with <scp>LY</scp> 2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Sitagliptin; Medicine; Internal medicine; Endocrinology; Placebo; Metformin; Glycated hemoglobin; Type 2 diabetes; Glucagon receptor; Blood pressure; Lipid profile; Glucagon-like peptide 1 receptor; Glucagon; Diabetes mellitus; Insulin; Receptor","authors":[{"name":"Cristina B. Guzmán","is_ca":false},{"name":"Xiaotian Michelle Zhang","is_ca":true},{"name":"Rong Liu","is_ca":false},{"name":"Arie Regev","is_ca":false},{"name":"Sudha S. Shankar","is_ca":false},{"name":"Parag Garhyan","is_ca":false},{"name":"Sreekumar Pillai","is_ca":false},{"name":"Christof Kazda","is_ca":false},{"name":"Naga Chalasani","is_ca":false},{"name":"Thomas A. Hardy","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008540022634781116,"gpt":0.2100609367524394,"spread":0.2015209141176582,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004541866,0.0003023109,0.0007881254,0.000124917,0.0001222495,0.0002904169,0.0001697249,0.0003047588,0.001191329],"category_scores_gemma":[0.0005586495,0.0001286909,0.0003473438,0.000170744,0.0002140891,0.0001968692,0.0001035035,0.0005789232,0.0002426498],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001742151,"about_ca_system_score_gemma":0.000205334,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002256221,"about_ca_topic_score_gemma":0.0006803176,"domain_scores_codex":[0.9998289,0.00007564396,0.00002305862,0.00002146873,0.00003372159,0.00001723926],"domain_scores_gemma":[0.9996444,0.00008226935,0.0001655873,0.00001365866,0.00001667702,0.00007738381],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.3949275,0.01248497,0.09099688,0.001740663,0.002600479,0.0009213393,0.0002374059,0.001592258,0.1493307,0.0001803643,0.003341081,0.3416464],"study_design_scores_gemma":[0.162428,0.4159557,0.3845055,0.0002054008,0.00162014,0.004369156,0.0002276033,0.004319256,0.0212588,0.0002605775,0.004776401,0.00007348844],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958877,0.003136392,0.0001095222,0.000157124,0.00003062155,0.00003740695,0.00007776562,0.00002398231,0.0005394911],"genre_scores_gemma":[0.9977118,0.001224933,0.0003220892,0.0002599683,0.00008866184,0.00004338027,0.0001666819,0.000003700195,0.0001787282],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001191329,"threshold_uncertainty_score":0.003985345,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2954115740","doi":"10.1111/dom.13820","title":"Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infection: A population‐based study of older women and men with diabetes","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Alberta; Ontario Drug Policy Research Network; Institute for Clinical Evaluative Sciences; Women's College Hospital; University of Toronto","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Dapagliflozin; Hazard ratio; Diabetes mellitus; Internal medicine; Cohort study; Population; Incidence (geometry); Urinary system; Cohort; Retrospective cohort study; Confidence interval; Type 2 diabetes; Endocrinology","authors":[{"name":"Iliana C. Lega","is_ca":true},{"name":"Susan E. Bronskill","is_ca":true},{"name":"Michael A. Campitelli","is_ca":true},{"name":"Jun Guan","is_ca":true},{"name":"Nathan M. Stall","is_ca":true},{"name":"Kenneth Lam","is_ca":true},{"name":"Lisa McCarthy","is_ca":true},{"name":"Andrea Gruneir","is_ca":true},{"name":"Paula A. Rochon","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.004257821987359529,"gpt":0.1978892058495821,"spread":0.1936313838622226,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000404732,0.0002903025,0.0004586654,0.0005869069,0.0005716008,0.0006591222,0.0002919078,0.0004367357,0.0009324289],"category_scores_gemma":[0.001001451,0.0004298904,0.0005555541,0.001375053,0.0002595613,0.0003814146,0.0003132516,0.0005802598,0.0001575735],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006004373,"about_ca_system_score_gemma":0.0005663885,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.06696896,"about_ca_topic_score_gemma":0.07326663,"domain_scores_codex":[0.9996827,0.00005385933,0.000031236,0.00008056272,0.0000832751,0.00006842795],"domain_scores_gemma":[0.9994223,0.00004845895,0.0002566891,0.00004725115,0.00007272455,0.0001526322],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00004219142,0.00001763139,0.9994804,0.000003537637,0.00004348943,0.00002404295,0.00003793013,0.000006791799,0.00005384043,0.000003693666,0.00003575546,0.0002507597],"study_design_scores_gemma":[0.000008710213,0.00004274869,0.9996139,0.000003605186,0.00002715482,0.00008645888,0.00007867382,0.00004259795,0.000007484216,0.000004782212,0.00008244663,0.000001433497],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987907,0.0003889391,0.00004519831,0.00003659308,0.000006787928,0.000009161165,0.0004478175,0.000002130485,0.0002726026],"genre_scores_gemma":[0.9991352,0.0002405628,0.00004737608,0.00004643937,0.00001339489,0.000007298052,0.000330393,8.663027e-7,0.0001784837],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06696896,"threshold_uncertainty_score":0.1331583,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3199001556","doi":"10.1111/dom.14551","title":"Gastrointestinal tolerability of once‐weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"LMC Diabetes & Endocrinology (Canada); McMaster University; York University","funders":"","keywords":"Semaglutide; Weight loss; Tolerability; Overweight; Adverse effect; Medicine; Obesity; Weight management; Gastrointestinal system; Anti obesity; Internal medicine; Endocrinology; Diabetes mellitus; Type 2 diabetes","authors":[{"name":"Sean Wharton","is_ca":true},{"name":"Salvatore Calanna","is_ca":false},{"name":"Melanie J. Davies","is_ca":false},{"name":"Dror Dicker","is_ca":false},{"name":"Bryan Goldman","is_ca":false},{"name":"Ildiko Lingvay","is_ca":false},{"name":"Ofri Mosenzon","is_ca":false},{"name":"Domenica Rubino","is_ca":false},{"name":"Mette S. Thomsen","is_ca":false},{"name":"Thomas A. Wadden","is_ca":false},{"name":"Sue D. Pedersen","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01349681993986193,"gpt":0.2352660898053299,"spread":0.2217692698654679,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00341366,0.0002847627,0.0006668907,0.000332978,0.0001246345,0.0003503773,0.0001535775,0.0003361023,0.0009483818],"category_scores_gemma":[0.00411719,0.0002059457,0.001225698,0.0004681201,0.0001519126,0.0003421438,0.0002102691,0.0005273367,0.00008675921],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001969464,"about_ca_system_score_gemma":0.0002244048,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006839729,"about_ca_topic_score_gemma":0.001553561,"domain_scores_codex":[0.9990574,0.000454084,0.0001427233,0.0001227624,0.0001780071,0.00004502511],"domain_scores_gemma":[0.9966718,0.001093517,0.001871948,0.00008990311,0.0001633378,0.000109498],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03908636,0.0004769834,0.8825613,0.001503116,0.007675272,0.0001591649,0.0001437271,0.0004636811,0.003476681,0.00004215351,0.000359167,0.06405239],"study_design_scores_gemma":[0.0009750359,0.006725115,0.9880619,0.00009349179,0.002469849,0.00028704,0.00004315003,0.000453045,0.0003937522,0.00003791601,0.0004513388,0.000008425486],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9872109,0.01149518,0.0002955598,0.0001251968,0.00002380921,0.00006119486,0.0002858303,0.00001077302,0.0004916526],"genre_scores_gemma":[0.997865,0.001348105,0.0002668358,0.00011633,0.00003814487,0.00003933268,0.0001805995,0.000002322122,0.0001433565],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00341366,"threshold_uncertainty_score":0.01805341,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2034171544","doi":"10.1111/j.1463-1326.2011.01362.x","title":"Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes","year":2011,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Sitagliptin; Postprandial; Type 2 diabetes; Internal medicine; Endocrinology; Diabetes mellitus; Insulin","authors":[{"name":"Angelo Tremblay","is_ca":true},{"name":"Benoı̂t Lamarche","is_ca":true},{"name":"Carolyn F. Deacon","is_ca":false},{"name":"S. John Weisnagel","is_ca":true},{"name":"Patrick Couture","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01016818649714533,"gpt":0.2110672270830369,"spread":0.2008990405858916,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007263308,0.0004857437,0.001138099,0.0002144254,0.0002387105,0.0003812823,0.0001659305,0.0005458114,0.001199907],"category_scores_gemma":[0.0008784077,0.000170578,0.0005033075,0.0002400967,0.0001981443,0.0002053994,0.0001741995,0.0008133437,0.0001838368],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001598439,"about_ca_system_score_gemma":0.0002010897,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000266468,"about_ca_topic_score_gemma":0.0005322291,"domain_scores_codex":[0.999763,0.0001102039,0.00003813587,0.00002594848,0.00003873801,0.00002398051],"domain_scores_gemma":[0.9995221,0.0001792771,0.000111404,0.0000172857,0.00002612531,0.0001438839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.439495,0.01361317,0.2354065,0.001622386,0.002891319,0.001372073,0.0003724086,0.0009636743,0.05117645,0.00007879954,0.001773941,0.2512343],"study_design_scores_gemma":[0.03128871,0.1978129,0.7573987,0.0001517408,0.001699995,0.001499519,0.0002711944,0.00144096,0.005295502,0.00009015507,0.003009783,0.00004091145],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932707,0.005627964,0.0000900895,0.0001314065,0.00005674444,0.00004354732,0.00007504538,0.00002027285,0.0006843123],"genre_scores_gemma":[0.9964921,0.002051318,0.0003343837,0.0003724572,0.0001036381,0.00006986007,0.0002373615,0.000003676874,0.0003352383],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001199907,"threshold_uncertainty_score":0.004014075,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2005227623","doi":"10.1111/j.1463-1326.2009.01110.x","title":"Zinc, a regulator of islet function and glucose homeostasis","year":2009,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Trace Elements in Health","field":"Nursing","cited_by":160,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Islet; Glucose homeostasis; Zinc; Endocrinology; Internal medicine; Diabetes mellitus; Pancreas; Insulin; Homeostasis; Biology; Pancreatic islets; Regulator; Insulin resistance; Chemistry; Medicine; Biochemistry; Gene","authors":[{"name":"Nadeeja Wijesekara","is_ca":true},{"name":"Fabrice Chimienti","is_ca":false},{"name":"Michael B. Wheeler","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02254266380466902,"gpt":0.2921141168304629,"spread":0.2695714530257939,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002118753,0.0005607505,0.0008557722,0.001031816,0.0002837189,0.0006659025,0.0005802521,0.0007429368,0.00194391],"category_scores_gemma":[0.0002815862,0.0001210395,0.000184559,0.001419394,0.000411016,0.0005054997,0.0005346931,0.0006576662,0.00139094],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004242553,"about_ca_system_score_gemma":0.0006707259,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002200112,"about_ca_topic_score_gemma":0.00255469,"domain_scores_codex":[0.9998857,0.00001870859,0.00001683957,0.00002191055,0.00004457565,0.00001224436],"domain_scores_gemma":[0.9999285,0.00002405006,0.0000140014,0.00000285087,0.0000191099,0.00001165821],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007081508,0.00005564906,0.0004779722,0.006365607,0.00005795003,0.0003687329,0.0001038715,0.0002530905,0.007549105,0.002822471,0.01836603,0.9635088],"study_design_scores_gemma":[0.00001802281,0.00009651679,0.002403531,0.001635478,0.00006100854,0.002830343,0.0001617535,0.00007968344,0.002028722,0.003473331,0.9871946,0.00001717397],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003575853,0.9975765,0.000201724,0.0002343959,0.0001177,0.000002426899,0.00001377645,0.00001142818,0.001484525],"genre_scores_gemma":[0.003649053,0.994188,0.0003121361,0.0001272347,0.0001295615,0.000005757131,0.00002389156,0.000001909693,0.001562366],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002200112,"threshold_uncertainty_score":0.006503046,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2061883499","doi":"10.1111/dom.12262","title":"A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (<scp>BEGIN</scp>: <scp>VICTOZA ADD‐ON</scp>)","year":2014,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Novo Nordisk; American Diabetes Association","keywords":"Insulin degludec; Medicine; Internal medicine; Insulin aspart; Endocrinology; Lira; Metformin; Insulin; Basal insulin; Type 2 diabetes; Hypoglycemia; Diabetes mellitus; Insulin glargine","authors":[{"name":"Chantal Mathieu","is_ca":false},{"name":"Helena W. Rodbard","is_ca":false},{"name":"Bertrand Cariou","is_ca":false},{"name":"Yehuda Handelsman","is_ca":false},{"name":"Athena Philis‐Tsimikas","is_ca":false},{"name":"Ann Marie Ocampo Francisco","is_ca":false},{"name":"Ashma Rana","is_ca":false},{"name":"Bernard Zinman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0215930071889278,"gpt":0.2575520745690506,"spread":0.2359590673801228,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001212228,0.001360858,0.002977824,0.0004065012,0.0002414885,0.0009957161,0.001005989,0.001546575,0.005152564],"category_scores_gemma":[0.001867789,0.0007751077,0.002296875,0.0003583866,0.0007120391,0.001006959,0.0004273415,0.002513403,0.0007592248],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007389889,"about_ca_system_score_gemma":0.000910865,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001292312,"about_ca_topic_score_gemma":0.002480191,"domain_scores_codex":[0.999167,0.0004895665,0.00006877784,0.0001376943,0.00005637626,0.00008070668],"domain_scores_gemma":[0.9988207,0.0004623792,0.0002301874,0.00007947601,0.00004595483,0.0003612687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9859414,0.003473549,0.000187981,0.0002392477,0.0004756589,0.00001238885,0.00002166478,0.0001087566,0.001151538,0.00002009756,0.00008809796,0.008279631],"study_design_scores_gemma":[0.803398,0.1909035,0.002783184,0.00005201343,0.001275061,0.00003328872,0.00003956528,0.0005722605,0.0005810297,0.0000786392,0.0002647573,0.00001877739],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946007,0.002862532,0.0002339741,0.0002339449,0.0002619216,0.0005913967,0.0002290641,0.00005742828,0.0009292294],"genre_scores_gemma":[0.9940995,0.001961205,0.000944188,0.000361693,0.0002308892,0.0007109001,0.0003243068,0.00001384562,0.00135363],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005152564,"threshold_uncertainty_score":0.01723701,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2808271763","doi":"10.1111/dom.13353","title":"Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline <scp>BMI</scp> or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"ExxonMobil Research and Engineering Company; Novo Nordisk","keywords":"Semaglutide; Nausea; Weight loss; Vomiting; Medicine; Sitagliptin; Type 2 diabetes; Placebo; Internal medicine; Dulaglutide; Adverse effect; Gastroenterology; Exenatide; Liraglutide; Diabetes mellitus; Obesity; Endocrinology","authors":[{"name":"Bo Åhrén","is_ca":false},{"name":"Stephen L. Atkin","is_ca":false},{"name":"G. Charpentier","is_ca":false},{"name":"Mark Warren","is_ca":false},{"name":"John Wilding","is_ca":false},{"name":"Anders G. Holst","is_ca":false},{"name":"Lawrence A. Leiter","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01985558255236574,"gpt":0.2665220678581215,"spread":0.2466664853057557,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002068177,0.0007310598,0.001740739,0.0003023213,0.0002281592,0.0007530528,0.0004083143,0.0007907516,0.003287664],"category_scores_gemma":[0.002222579,0.0003284646,0.002373247,0.0003858655,0.0003593671,0.0004878174,0.0002769022,0.001004984,0.0002441327],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003364967,"about_ca_system_score_gemma":0.0005187545,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005429097,"about_ca_topic_score_gemma":0.002290384,"domain_scores_codex":[0.9991986,0.0004550321,0.0001367938,0.00006646746,0.00008350678,0.00005962277],"domain_scores_gemma":[0.999243,0.000237755,0.0002940655,0.00005136593,0.00006796895,0.0001056999],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.8871437,0.002670988,0.008404975,0.007350313,0.01100938,0.0001624654,0.0001546978,0.0004452919,0.006627488,0.0002536076,0.001887118,0.07389002],"study_design_scores_gemma":[0.7615791,0.1794884,0.03794185,0.0009989676,0.0118778,0.0004003745,0.0001525649,0.0007370865,0.002576804,0.0005024993,0.003704866,0.00003964895],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9563434,0.03696408,0.0005063607,0.0006061812,0.0003003956,0.001234462,0.0006342869,0.0001247979,0.003286104],"genre_scores_gemma":[0.9885038,0.008155229,0.0006047836,0.0005109365,0.0002153708,0.0007011579,0.0006090723,0.00001001858,0.0006895525],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003287664,"threshold_uncertainty_score":0.01099837,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1982950261","doi":"10.1111/j.1463-1326.2011.01554.x","title":"Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial","year":2011,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Royal Alexandra Hospital; University of Alberta","funders":"","keywords":"Medicine; Sibutramine; Weight loss; Internal medicine; Cardiology; Obesity","authors":[{"name":"Ian D. Caterson","is_ca":false},{"name":"Nick Finer","is_ca":false},{"name":"Walmir Coutinho","is_ca":false},{"name":"Luc F. Van Gaal","is_ca":false},{"name":"Aldo P. Maggioni","is_ca":false},{"name":"Christian Torp‐Pedersen","is_ca":false},{"name":"Arya M. Sharma","is_ca":true},{"name":"Udo F. Legler","is_ca":false},{"name":"G Shepherd","is_ca":false},{"name":"Richard A. Rode","is_ca":false},{"name":"Renee Perdok","is_ca":false},{"name":"Cheryl Renz","is_ca":false},{"name":"W. P. T. James","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02690187576765485,"gpt":0.2483579855067467,"spread":0.2214561097390919,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007511835,0.0005928738,0.001011156,0.0001564599,0.0002051698,0.0005057286,0.0002761002,0.0005775609,0.002471057],"category_scores_gemma":[0.0008499221,0.0001224212,0.0009453119,0.0002265832,0.0002192246,0.0002771396,0.0003060076,0.0009660357,0.0002324544],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002230503,"about_ca_system_score_gemma":0.0003790935,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007881529,"about_ca_topic_score_gemma":0.001892239,"domain_scores_codex":[0.9998109,0.00008726801,0.00001862987,0.00002628833,0.00003082973,0.00002611104],"domain_scores_gemma":[0.9996139,0.00007511256,0.0001309465,0.00003211101,0.00003022641,0.0001176264],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8421918,0.004972038,0.02123074,0.002657656,0.006845834,0.0001329082,0.00008507094,0.0006014609,0.005272422,0.000199942,0.003625176,0.1121849],"study_design_scores_gemma":[0.6951329,0.1101401,0.1753472,0.0007014742,0.01048048,0.0003081174,0.00007824507,0.001080331,0.002238367,0.0005485839,0.003909354,0.00003485002],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9838393,0.0116999,0.0002927653,0.0005217008,0.0001975695,0.0003102178,0.001166524,0.00006104649,0.00191103],"genre_scores_gemma":[0.9872383,0.006792359,0.0005455128,0.0007536283,0.0003299974,0.0004167664,0.002374366,0.00001454074,0.001534641],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002471057,"threshold_uncertainty_score":0.008266509,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2039664878","doi":"10.1111/j.1463-1326.2012.01637.x","title":"Effect of anti‐ <scp>IL</scp> ‐1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo‐controlled trial","year":2012,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Particle Physics","funders":"Novartis Pharmaceuticals Corporation; Novartis","keywords":"Medicine; Canakinumab; Metformin; Internal medicine; Placebo; Insulin; Sulfonylurea; Type 2 diabetes; Endocrinology; Diabetes mellitus; Impaired glucose tolerance; Insulin resistance","authors":[{"name":"A Rissanen","is_ca":false},{"name":"Campbell P. Howard","is_ca":false},{"name":"Jaco Botha","is_ca":false},{"name":"Tom Thurén","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008338072323909101,"gpt":0.2653110258040003,"spread":0.2569729534800912,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002710332,0.001746706,0.00404478,0.0004767667,0.0003975565,0.001263943,0.0009651171,0.002473606,0.005981646],"category_scores_gemma":[0.003150479,0.0007565507,0.002457622,0.0005056375,0.001223317,0.0009326222,0.0003689651,0.00248705,0.0008067772],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007563485,"about_ca_system_score_gemma":0.000903189,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008115882,"about_ca_topic_score_gemma":0.00130246,"domain_scores_codex":[0.9988806,0.0006433951,0.0001001215,0.0001761274,0.00008627219,0.0001134785],"domain_scores_gemma":[0.9981993,0.0007480734,0.000468525,0.0001240673,0.0001167696,0.0003434143],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9887902,0.001582548,0.0002695289,0.0006525395,0.0009464262,0.00001715505,0.00001383486,0.00009581615,0.0009624094,0.00002305426,0.0001955347,0.006450937],"study_design_scores_gemma":[0.9736817,0.02446097,0.0008222352,0.00003124623,0.0005387606,0.00001306232,0.000005317046,0.0001096536,0.0001770137,0.00002763791,0.0001271602,0.00000515597],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9788088,0.01365158,0.0005128732,0.0006917614,0.0009001592,0.002687538,0.0006786488,0.0001430791,0.001925431],"genre_scores_gemma":[0.9862409,0.005948902,0.001015265,0.0008866598,0.0008049274,0.002530111,0.0007063141,0.00002345469,0.001843509],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005981646,"threshold_uncertainty_score":0.02001065,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2756174617","doi":"10.1111/dom.13114","title":"Efficacy and safety of alirocumab in insulin‐treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The <scp>ODYSSEY DM‐INSULIN</scp> randomized trial","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Internal medicine; Type 2 diabetes; Endocrinology; Placebo; Type 1 diabetes; Cholesterol; Insulin; Diabetes mellitus; PCSK9; Population; Apolipoprotein B; Lipoprotein; Apolipoprotein A1; LDL receptor","authors":[{"name":"Lawrence A. Leiter","is_ca":true},{"name":"Bertrand Cariou","is_ca":false},{"name":"Dirk Müller‐Wieland","is_ca":false},{"name":"Helen M. Colhoun","is_ca":false},{"name":"Stefano Del Prato","is_ca":false},{"name":"Francisco J. Tinahones","is_ca":false},{"name":"Kausik K. Ray","is_ca":false},{"name":"Maja Bujas‐Bobanovic","is_ca":false},{"name":"Catherine Domenger","is_ca":false},{"name":"Jonas Mandel","is_ca":false},{"name":"Rita Samuel","is_ca":false},{"name":"Robert R. Henry","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01075347439363494,"gpt":0.2304660606959438,"spread":0.2197125863023089,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001596624,0.001267529,0.001951855,0.0003214531,0.0004129569,0.001079162,0.0005384835,0.001346751,0.004062578],"category_scores_gemma":[0.001885105,0.0004244875,0.001655541,0.0002658232,0.0007212235,0.0005939688,0.0003571036,0.001912361,0.0004929916],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000561911,"about_ca_system_score_gemma":0.0007383079,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00114636,"about_ca_topic_score_gemma":0.002391219,"domain_scores_codex":[0.9993993,0.0003413314,0.00004827725,0.00009422751,0.00004777422,0.00006907599],"domain_scores_gemma":[0.9992164,0.0001661527,0.0002649815,0.00005293443,0.00005481658,0.0002446361],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.982357,0.002265527,0.002330612,0.0005590064,0.001092404,0.00003591679,0.00002725537,0.0001323298,0.001129607,0.00006554968,0.0005682269,0.009436537],"study_design_scores_gemma":[0.9639509,0.02692662,0.006250244,0.00007197974,0.001354648,0.00007001129,0.0000196608,0.0003857816,0.0002994343,0.0001079169,0.0005496995,0.00001310024],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885879,0.006143115,0.0002628033,0.0007008813,0.0003441999,0.001246685,0.0006114044,0.00004770564,0.002055266],"genre_scores_gemma":[0.9904181,0.002841755,0.0007942934,0.00112056,0.0004602848,0.001600659,0.0008808817,0.00001157818,0.001871855],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004062578,"threshold_uncertainty_score":0.01359063,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2135287300","doi":"10.1111/j.1463-1326.2009.01125.x","title":"Insulin use and increased risk of mortality in type 2 diabetes: a cohort study","year":2009,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; U.S. Department of Veterans Affairs","keywords":"Medicine; Hazard ratio; Insulin; Confidence interval; Proportional hazards model; Diabetes mellitus; Type 2 diabetes; Population; Internal medicine; Cohort; Cohort study; Demography; Endocrinology; Environmental health","authors":[{"name":"John‐Michael Gamble","is_ca":true},{"name":"Scot H. Simpson","is_ca":true},{"name":"Dean T. Eurich","is_ca":true},{"name":"Sumit R. Majumdar","is_ca":true},{"name":"Jeffrey Johnson","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01269773405836331,"gpt":0.2390475774159947,"spread":0.2263498433576314,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009801376,0.0004593256,0.0004386816,0.0007653061,0.0004318838,0.0009055505,0.0005435249,0.0006168487,0.001106104],"category_scores_gemma":[0.002342687,0.0005046906,0.0008393315,0.001406719,0.0002184136,0.0004550965,0.0004463319,0.0008748982,0.0001920121],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004206105,"about_ca_system_score_gemma":0.0004676747,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01865804,"about_ca_topic_score_gemma":0.01859001,"domain_scores_codex":[0.99941,0.0001692163,0.00006132888,0.0001453462,0.0001159488,0.00009815855],"domain_scores_gemma":[0.998519,0.0002284151,0.0006445892,0.0001761234,0.000159558,0.0002724014],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002268066,0.00004624474,0.9987494,0.000007103631,0.0002354269,0.00005086063,0.00003269064,0.00003017588,0.00008155224,0.000005569529,0.00005629114,0.0004778037],"study_design_scores_gemma":[0.00002529643,0.0000961441,0.9992508,0.000007046921,0.0001003465,0.0001644359,0.00005852271,0.000160177,0.00002407539,0.00001038533,0.00009822297,0.000004439147],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984608,0.0004223807,0.00007872851,0.00004535365,0.00001281618,0.00001218222,0.0007480849,0.000003775118,0.0002157514],"genre_scores_gemma":[0.9983271,0.0004309228,0.0001416394,0.00004079946,0.00002450947,0.00001623174,0.0007955114,0.000002578937,0.0002206161],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01865804,"threshold_uncertainty_score":0.03709888,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1975929001","doi":"10.1111/dom.12121","title":"Efficacy and safety of lixisenatide once daily versus placebo in type 2 diabetes insufficiently controlled on pioglitazone ( <scp>GetGoal</scp> ‐P)","year":2013,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"American Diabetes Association","keywords":"Lixisenatide; Placebo; Medicine; Pioglitazone; Internal medicine; Adverse effect; Metformin; Type 2 diabetes; Randomized controlled trial; Clinical endpoint; Diabetes mellitus; Endocrinology","authors":[{"name":"M. Pinget","is_ca":false},{"name":"Ronald Goldenberg","is_ca":true},{"name":"Elisabeth Niemoeller","is_ca":false},{"name":"Isabel Muehlen-Bartmer","is_ca":false},{"name":"Hailing Guo","is_ca":false},{"name":"Ronnie Aronson","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009655752413255798,"gpt":0.2276453307407597,"spread":0.2179895783275039,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002083253,0.0008724299,0.003439096,0.0005743196,0.0003488939,0.00104911,0.0006820516,0.001901923,0.003581228],"category_scores_gemma":[0.002352987,0.0006404781,0.001492884,0.000407396,0.0008469445,0.001130835,0.000392763,0.001726188,0.0004209011],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004849792,"about_ca_system_score_gemma":0.0006237309,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003355526,"about_ca_topic_score_gemma":0.0004849029,"domain_scores_codex":[0.9989396,0.0005891284,0.0001412893,0.0001481627,0.0001066567,0.00007520941],"domain_scores_gemma":[0.998385,0.0005675746,0.0004675466,0.00009290806,0.00007404466,0.0004130072],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9718199,0.006498947,0.000541122,0.0005927545,0.0005507065,0.00002187334,0.00003067395,0.0001265228,0.004805882,0.0000340039,0.0001095089,0.01486798],"study_design_scores_gemma":[0.7344097,0.2586835,0.003444268,0.00007321669,0.0007921861,0.00004568772,0.00003318082,0.0004308085,0.001672963,0.00008415399,0.0003110884,0.00001912005],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920946,0.005983243,0.0002400503,0.0002180674,0.0002268275,0.0005012281,0.0001905218,0.00004660952,0.0004988431],"genre_scores_gemma":[0.994787,0.002356262,0.0006969579,0.0003170368,0.0002336362,0.0007027427,0.0002171385,0.000009489311,0.0006797388],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003581228,"threshold_uncertainty_score":0.01198041,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2890415448","doi":"10.1111/dom.13522","title":"Glucagon‐like peptide‐1 receptor agonists for antipsychotic‐associated cardio‐metabolic risk factors: A systematic review and individual participant data meta‐analysis","year":2018,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Lundbeckfonden; Steno Diabetes Center Copenhagen","keywords":"Medicine; Glucagon-like peptide-1; Antipsychotic; Glucagon-like peptide 1 receptor; Meta-analysis; Pharmacology; Internal medicine; Diabetes mellitus; Endocrinology; Receptor; Schizophrenia (object-oriented programming); Type 2 diabetes; Agonist; Psychiatry","authors":[{"name":"Dan Siskind","is_ca":false},{"name":"Margaret Hahn","is_ca":true},{"name":"Christoph U. Correll","is_ca":false},{"name":"Anders Fink‐Jensen","is_ca":false},{"name":"Anthony Russell","is_ca":false},{"name":"Nikolaj Bak","is_ca":false},{"name":"Brian V. Broberg","is_ca":false},{"name":"Julie Rask Larsen","is_ca":false},{"name":"Pelle L. Ishøy","is_ca":false},{"name":"Tina Vilsbøll","is_ca":false},{"name":"Filip K. Knop","is_ca":false},{"name":"Steve Kisely","is_ca":false},{"name":"Bjørn H. Ebdrup","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.147736464597099,"gpt":0.3460003284333762,"spread":0.1982638638362772,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01271121,0.002638643,0.02110693,0.005310185,0.0006171794,0.002894822,0.002072933,0.002354358,0.003858533],"category_scores_gemma":[0.02684289,0.001466839,0.03376477,0.005990875,0.000740185,0.001634702,0.001401484,0.00178867,0.0003393589],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002434359,"about_ca_system_score_gemma":0.00391774,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006235551,"about_ca_topic_score_gemma":0.01502538,"domain_scores_codex":[0.9919464,0.004038292,0.002242974,0.0007878497,0.0007610174,0.0002234618],"domain_scores_gemma":[0.9871196,0.009175443,0.002121838,0.0004106002,0.0009862815,0.0001862974],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002006377,0.00002897223,0.001721513,0.4378091,0.5481326,0.0000939784,0.00006611821,0.0003223702,0.0002134985,0.0001038506,0.0004609652,0.009040729],"study_design_scores_gemma":[0.0007054118,0.0001955724,0.001667411,0.02626638,0.9695323,0.0000697959,0.00003120852,0.000111816,0.00008235943,0.0001237518,0.001196714,0.00001721635],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004506217,0.9931002,0.0007122511,0.0001930026,0.0001546707,0.0005134759,0.00056227,0.0000330776,0.0002248168],"genre_scores_gemma":[0.1468947,0.8452029,0.003005715,0.001011427,0.0002062175,0.002243788,0.001016062,0.00004022156,0.0003789124],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02110693,"threshold_uncertainty_score":0.06722414,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2550794647","doi":"10.1111/dom.12821","title":"Cardiovascular events and all‐cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: <scp>A B</scp> ayesian meta‐analysis of survival data","year":2016,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Simon Fraser University; MD Precision (Canada); Precision Nanosystems (Canada); University of British Columbia","funders":"","keywords":"Medicine; Meta-analysis; Internal medicine; Hazard ratio; Observational study; Placebo; Randomized controlled trial; Relative risk; Myocardial infarction; Stroke (engine); Confidence interval; Sitagliptin; Type 2 diabetes; Diabetes mellitus; Pharmacology; Insulin; Endocrinology; Metformin","authors":[{"name":"Steve Bain","is_ca":false},{"name":"Eric Druyts","is_ca":true},{"name":"Chakrapani Balijepalli","is_ca":true},{"name":"Carl A. Baxter","is_ca":false},{"name":"Craig J. Currie","is_ca":false},{"name":"Romita Das","is_ca":false},{"name":"Richard Donnelly","is_ca":false},{"name":"Kamlesh Khunti","is_ca":false},{"name":"Haya Langerman","is_ca":false},{"name":"Paul Leigh","is_ca":false},{"name":"Gaye Siliman","is_ca":true},{"name":"Kristian Thorlund","is_ca":true},{"name":"Kabirraaj Toor","is_ca":true},{"name":"Jiten Vora","is_ca":false},{"name":"Edward J. Mills","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07167600119653196,"gpt":0.3062117333737652,"spread":0.2345357321772333,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01496771,0.002454237,0.01208115,0.005457652,0.0005044965,0.002730797,0.001154701,0.001891613,0.002537577],"category_scores_gemma":[0.02001422,0.00114742,0.0489367,0.004530062,0.0005138115,0.001079317,0.001219775,0.001667808,0.0002026514],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001624348,"about_ca_system_score_gemma":0.002110919,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004372368,"about_ca_topic_score_gemma":0.008433651,"domain_scores_codex":[0.990043,0.006104628,0.001911313,0.0007765968,0.0009240265,0.0002403404],"domain_scores_gemma":[0.9892398,0.007626619,0.001771617,0.0004638757,0.0007392127,0.0001588917],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.003273795,0.00003031179,0.004936015,0.09806249,0.8846219,0.00007067417,0.00003256629,0.0005171316,0.0002644693,0.00008240754,0.0004502997,0.007657903],"study_design_scores_gemma":[0.001004909,0.0003076221,0.004818696,0.007131262,0.9852384,0.00006767111,0.00002104739,0.0003211267,0.000130342,0.0001425489,0.0008016528,0.00001477852],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01774973,0.9791427,0.001050641,0.0004074773,0.0003371886,0.0003003935,0.0005931382,0.00003772037,0.0003810291],"genre_scores_gemma":[0.4280604,0.561255,0.005244969,0.00143287,0.0006857566,0.00129538,0.001335122,0.00004507609,0.0006451847],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01496771,"threshold_uncertainty_score":0.07915777,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1606810773","doi":"10.1111/dom.12498","title":"One‐year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26‐week extension to a 26‐week main trial","year":2015,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Johnson and Johnson; Janssen Pharmaceuticals; Novartis Pharmaceuticals Corporation; Novo Nordisk; Sanofi; Merck; Takeda Pharmaceutical Company; Eli Lilly and Company; Boehringer Ingelheim","keywords":"Medicine; Insulin degludec; Liraglutide; Type 2 diabetes; Diabetes mellitus; Internal medicine; Endocrinology; Basal insulin","authors":[{"name":"Stephen Gough","is_ca":false},{"name":"Bruce W. Bode","is_ca":false},{"name":"Vincent Woo","is_ca":true},{"name":"Helena W. Rodbard","is_ca":false},{"name":"Sultan Linjawi","is_ca":false},{"name":"M. Zacho","is_ca":false},{"name":"Pamela D. Reiter","is_ca":false},{"name":"John B. Buse","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01926542420580191,"gpt":0.2314381304544267,"spread":0.2121727062486247,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003084877,0.001896028,0.003376101,0.0003726482,0.0003713442,0.001294579,0.0008697626,0.00135451,0.003542115],"category_scores_gemma":[0.001919718,0.0008026861,0.00314835,0.0003163268,0.0007990717,0.001071919,0.0005639228,0.003518585,0.0008424729],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006888667,"about_ca_system_score_gemma":0.0007204387,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005200754,"about_ca_topic_score_gemma":0.0007721323,"domain_scores_codex":[0.999106,0.0004125679,0.00006141322,0.0001875259,0.00008022622,0.0001521044],"domain_scores_gemma":[0.9981522,0.000393453,0.0004780108,0.0002607064,0.0001226254,0.0005930004],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9784742,0.007066179,0.001439666,0.0001869757,0.0006367285,0.00003689503,0.00004245535,0.0002400665,0.002119408,0.00002064443,0.0002520378,0.009484759],"study_design_scores_gemma":[0.8040593,0.1842843,0.008951163,0.00003856597,0.0009420888,0.00006100962,0.00002475398,0.00032661,0.0006697478,0.00004474952,0.0005703659,0.00002719214],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959425,0.002159453,0.0002213391,0.0001526683,0.0001482757,0.0004131944,0.0003224648,0.00003845728,0.0006015571],"genre_scores_gemma":[0.9927689,0.001445033,0.0008310183,0.0004026796,0.000344882,0.0009869225,0.001048819,0.00001864432,0.002153218],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003542115,"threshold_uncertainty_score":0.01631463,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4353021269","doi":"10.1111/dom.15058","title":"Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of <scp>SOUL</scp> , a randomized trial","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"Novo Nordisk","keywords":"Semaglutide; Medicine; Type 2 diabetes; Randomized controlled trial; Kidney disease; Disease; Diabetes mellitus; Internal medicine; Physical therapy; Endocrinology","authors":[{"name":"Darren K. McGuire","is_ca":false},{"name":"Rodica Pop‐Busui","is_ca":false},{"name":"John Deanfield","is_ca":false},{"name":"Silvio E. Inzucchi","is_ca":false},{"name":"Johannes F.E. Mann","is_ca":false},{"name":"Nikolaus Marx","is_ca":false},{"name":"Sharon L. Mulvagh","is_ca":true},{"name":"Neil Poulter","is_ca":false},{"name":"Mads D.M. Engelmann","is_ca":false},{"name":"G. Kees Hovingh","is_ca":false},{"name":"Maria Sejersten Ripa","is_ca":false},{"name":"Mette Gislum","is_ca":false},{"name":"Kirstine Brown‐Frandsen","is_ca":false},{"name":"John B. Buse","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01100404731189123,"gpt":0.2201193185594245,"spread":0.2091152712475333,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005438344,0.001429257,0.002516385,0.0004354966,0.0004833466,0.00136758,0.0005732931,0.001756105,0.004178231],"category_scores_gemma":[0.003669813,0.0006033499,0.002079648,0.0005500721,0.001060634,0.0009361526,0.0005190935,0.001552492,0.0006132608],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005213242,"about_ca_system_score_gemma":0.001455657,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004026165,"about_ca_topic_score_gemma":0.001068888,"domain_scores_codex":[0.9968207,0.002213708,0.0002256405,0.0002890575,0.0002135975,0.0002372306],"domain_scores_gemma":[0.9984005,0.0004119873,0.0004386414,0.0001093212,0.0001402936,0.0004992635],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9835644,0.003475111,0.001844089,0.0006205824,0.001145581,0.00001696722,0.00002520131,0.0002223744,0.0007329258,0.0001736265,0.0004865705,0.007692561],"study_design_scores_gemma":[0.9511061,0.0432437,0.002975155,0.00006405367,0.001087638,0.00001597563,0.00001651038,0.000323382,0.0002312635,0.0002321445,0.0006909104,0.00001316049],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.9570565,0.01179789,0.001331659,0.001130534,0.0006924217,0.02065051,0.001800627,0.00009553346,0.005444263],"genre_scores_gemma":[0.9522378,0.003992546,0.003270549,0.001817303,0.0009305411,0.0332134,0.001612457,0.00002455418,0.002900915],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.005438344,"threshold_uncertainty_score":0.02876103,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2083415436","doi":"10.1111/j.1463-1326.2011.01493.x","title":"Achieving a clinically relevant composite outcome of an HbA1c of &lt;7% without weight gain or hypoglycaemia in type 2 diabetes: a meta‐analysis of the liraglutide clinical trial programme","year":2011,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Merck Sharp and Dohme; Novo Nordisk","keywords":"Liraglutide; Medicine; Sitagliptin; Glimepiride; Exenatide; Type 2 diabetes; Internal medicine; Weight loss; Rosiglitazone; Weight gain; Placebo; Diabetes mellitus; Endocrinology; Obesity","authors":[{"name":"Bernard Zinman","is_ca":true},{"name":"Wolfgang E. Schmidt","is_ca":false},{"name":"A C Moses","is_ca":false},{"name":"N. Lund","is_ca":false},{"name":"Stephen Gough","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1609040643722358,"gpt":0.3953648381021613,"spread":0.2344607737299255,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0232429,0.003550221,0.01701999,0.003389365,0.0005038626,0.00361724,0.002078816,0.002199483,0.003019416],"category_scores_gemma":[0.02538468,0.001645012,0.05699286,0.003829201,0.000696305,0.001456857,0.001488653,0.002572361,0.0004062871],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001842152,"about_ca_system_score_gemma":0.001331441,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004458821,"about_ca_topic_score_gemma":0.006863758,"domain_scores_codex":[0.9828064,0.01234004,0.002080733,0.001494946,0.0009250405,0.0003526513],"domain_scores_gemma":[0.98685,0.009192037,0.001930503,0.001051923,0.0006562446,0.0003192938],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.01348632,0.00002564236,0.002895876,0.0188682,0.9607047,0.00006998431,0.00002922775,0.0009311649,0.0002423385,0.00006337092,0.0003274195,0.002355797],"study_design_scores_gemma":[0.002649859,0.000358979,0.002561385,0.0008438168,0.9924628,0.00004893318,0.00001789216,0.0004492961,0.0001043523,0.000133691,0.0003507325,0.00001832852],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1170943,0.8701115,0.005525732,0.0009396809,0.0008962005,0.001000252,0.002397207,0.0002855846,0.00174939],"genre_scores_gemma":[0.9134458,0.07733901,0.003695389,0.001095543,0.0003866598,0.001126812,0.001747488,0.0001175249,0.001045783],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0232429,"threshold_uncertainty_score":0.1229217,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2048930008","doi":"10.1111/j.1463-1326.2009.01114.x","title":"Lipid receptors and islet function: therapeutic implications?","year":2009,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Diabetes Canada","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research","keywords":"Free fatty acid receptor 1; Receptor; G protein-coupled receptor; Enteroendocrine cell; Insulin; Secretion; Biology; Cell biology; Beta cell; Endocrinology; Islet; Internal medicine; Hormone; Agonist; Endocrine system; Biochemistry; Medicine","authors":[{"name":"Melkam A. Kebede","is_ca":true},{"name":"Thierry Alquier","is_ca":true},{"name":"Martin G. Latour","is_ca":false},{"name":"Vincent Poitout","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03198999510827581,"gpt":0.2871956774012498,"spread":0.255205682292974,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005567138,0.0009849408,0.001709825,0.001265394,0.0003066001,0.001294335,0.0008457586,0.001685677,0.005843904],"category_scores_gemma":[0.0006135702,0.0002362074,0.0003887039,0.001541432,0.0007614662,0.002061326,0.0006908225,0.002027378,0.004250458],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005539229,"about_ca_system_score_gemma":0.0005676924,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006912855,"about_ca_topic_score_gemma":0.001319495,"domain_scores_codex":[0.9998621,0.000036964,0.0000158462,0.00002241824,0.00004532272,0.00001736125],"domain_scores_gemma":[0.9998673,0.00005460729,0.00001673057,0.000008004052,0.00003342836,0.00001997523],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001636487,0.00008654913,0.0001422598,0.006877272,0.00005363211,0.0004671423,0.00008020273,0.0002881855,0.002034904,0.007115313,0.05338078,0.9293102],"study_design_scores_gemma":[0.00003389347,0.0000696694,0.0004183974,0.001722037,0.00003762223,0.001507474,0.0000884123,0.00005056059,0.0002313551,0.003564593,0.9922639,0.00001219353],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007801877,0.9976452,0.00006600058,0.0007307085,0.0003747341,0.000002012045,0.000007145677,0.000004635373,0.001091476],"genre_scores_gemma":[0.0006946425,0.9969597,0.0001324468,0.0005525899,0.000466079,0.000004817201,0.00001240059,0.000001369199,0.001175927],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005843904,"threshold_uncertainty_score":0.01954985,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2914902752","doi":"10.1111/dom.13642","title":"Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. John’s Health Sciences Centre","funders":"Amgen","keywords":"Medicine; Metformin; Type 2 diabetes; Kidney disease; Internal medicine; Diabetes mellitus; Disease; Endocrinology","authors":[{"name":"David M. Charytan","is_ca":false},{"name":"Scott D. Solomon","is_ca":false},{"name":"Peter Ivanovich","is_ca":false},{"name":"Giuseppe Remuzzi","is_ca":false},{"name":"Mark E. Cooper","is_ca":false},{"name":"Janet B. McGill","is_ca":false},{"name":"Hans‐Henrik Parving","is_ca":false},{"name":"Patrick S. Parfrey","is_ca":true},{"name":"Ajay Singh","is_ca":false},{"name":"Emmanuel A. Burdmann","is_ca":false},{"name":"Andrew S. Levey","is_ca":false},{"name":"Kai‐Uwe Eckardt","is_ca":false},{"name":"John J.V. McMurray","is_ca":false},{"name":"Larry A. Weinrauch","is_ca":false},{"name":"Jiankang Liu","is_ca":false},{"name":"Brian Claggett","is_ca":false},{"name":"Eldrin F. Lewis","is_ca":false},{"name":"Marc A. Pfeffer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005217562185070648,"gpt":0.1839735379072619,"spread":0.1787559757221913,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001295506,0.0002548244,0.0006019516,0.000548104,0.0003711379,0.0006790507,0.0002683283,0.0006057774,0.001362903],"category_scores_gemma":[0.003061837,0.0002453882,0.000953697,0.001072533,0.0001535851,0.0003920906,0.0004304674,0.0007386577,0.0001323882],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002554537,"about_ca_system_score_gemma":0.0003060645,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001596572,"about_ca_topic_score_gemma":0.00254947,"domain_scores_codex":[0.9992471,0.0002998434,0.0001127938,0.0001149418,0.0001455402,0.00007975683],"domain_scores_gemma":[0.9981914,0.0003822949,0.00104544,0.00007974258,0.0001059773,0.0001950974],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001512354,0.0001403757,0.9937928,0.00007346274,0.0004948982,0.00004888795,0.00002125754,0.00005549666,0.00008512234,0.0000163552,0.0001387446,0.003620283],"study_design_scores_gemma":[0.0001513131,0.0004696425,0.9982309,0.00002780307,0.0003205058,0.0001572352,0.00003469116,0.0002779135,0.00004232878,0.00004499129,0.0002371043,0.000005578467],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948012,0.003816878,0.0001197239,0.0001559716,0.00003837604,0.00002326142,0.000489598,0.0000034778,0.0005516062],"genre_scores_gemma":[0.9981438,0.0008277459,0.0001473815,0.0001074629,0.00006213492,0.00002515266,0.0004896206,0.000001158304,0.0001956482],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001596572,"threshold_uncertainty_score":0.006851375,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2133819196","doi":"10.1111/j.1463-1326.2007.00837.x","title":"Metabolomic profiling of dietary‐induced insulin resistance in the high fat–fed C57BL/6J mouse","year":2008,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":118,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Metabolomics; Insulin resistance; Metabolite; Internal medicine; Metabolome; Endocrinology; Biology; Insulin; Bioinformatics; Medicine","authors":[{"name":"Jane Shearer","is_ca":true},{"name":"Gavin E. Duggan","is_ca":true},{"name":"Aalim M. Weljie","is_ca":true},{"name":"Dustin S. Hittel","is_ca":true},{"name":"David H. Wasserman","is_ca":false},{"name":"Hans J. Vogel","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01454274252757815,"gpt":0.2209288852587834,"spread":0.2063861427312053,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003384786,0.0005310974,0.0004522768,0.0009742586,0.0002019135,0.0003601338,0.0001607439,0.0003575241,0.0005347566],"category_scores_gemma":[0.0001895418,0.0002314489,0.0003485875,0.0003768873,0.0002915217,0.0001903983,0.0001860376,0.0007034501,0.0001790128],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001974302,"about_ca_system_score_gemma":0.0001357496,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005115014,"about_ca_topic_score_gemma":0.001033199,"domain_scores_codex":[0.9998243,0.00002238923,0.00001369724,0.000062989,0.00004911374,0.00002751662],"domain_scores_gemma":[0.9997669,0.00002746565,0.00007746381,0.00003038955,0.00003690025,0.0000608112],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004377153,0.00004369856,0.001050807,0.00001644259,0.00001596656,0.00002932252,0.00001217057,0.00005465373,0.9972841,0.00002000105,0.00002633693,0.001008748],"study_design_scores_gemma":[0.00009491797,0.002644553,0.1723695,0.00002495894,0.0002290144,0.0005456703,0.0001152851,0.003838253,0.8180023,0.0002577081,0.001841707,0.00003607665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917829,0.00067071,0.005001786,0.0001084388,0.00001930058,0.00004589192,0.001819485,0.0001412199,0.0004102554],"genre_scores_gemma":[0.9797881,0.001274599,0.01222254,0.0002645412,0.00002084673,0.0001481741,0.002895887,0.0001206758,0.003264719],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009742586,"threshold_uncertainty_score":0.001790047,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2782920834","doi":"10.1111/dom.13217","title":"<scp>DECLARE‐TIMI</scp> 58: Participants’ baseline characteristics","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"AstraZeneca","keywords":"Medicine; TIMI; Baseline (sea); Internal medicine; Myocardial infarction; Percutaneous coronary intervention","authors":[{"name":"Itamar Raz","is_ca":false},{"name":"Ofri Mosenzon","is_ca":false},{"name":"Marc P. Bonaca","is_ca":false},{"name":"Avivit Cahn","is_ca":false},{"name":"Eri Kato","is_ca":false},{"name":"Michael G. Silverman","is_ca":false},{"name":"Deepak L. Bhatt","is_ca":false},{"name":"Lawrence A. Leiter","is_ca":true},{"name":"Darren K. McGuire","is_ca":false},{"name":"John Wilding","is_ca":false},{"name":"Ingrid Gause‐Nilsson","is_ca":false},{"name":"Anna Maria Langkilde","is_ca":false},{"name":"Peter A. Johansson","is_ca":false},{"name":"Marc S. Sabatine","is_ca":false},{"name":"Stephen D. Wiviott","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01928314700339614,"gpt":0.2485237473738867,"spread":0.2292406003704905,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001397093,0.0004453631,0.0005787602,0.000421458,0.000414113,0.0004314772,0.0002735012,0.0006646522,0.006707469],"category_scores_gemma":[0.002265794,0.0001960394,0.0005046295,0.0006143083,0.0002678577,0.0005387705,0.0002605757,0.0005467682,0.001858813],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002586303,"about_ca_system_score_gemma":0.0004630876,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006749739,"about_ca_topic_score_gemma":0.0005283114,"domain_scores_codex":[0.9992524,0.0002121009,0.00009743597,0.000188028,0.0001499818,0.000100024],"domain_scores_gemma":[0.9993101,0.0001051864,0.0003343544,0.00004779967,0.00009498053,0.0001075132],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.07102792,0.002457738,0.8432913,0.00104084,0.0009343213,0.0002881266,0.000538216,0.0004110686,0.00377069,0.0004425537,0.02720742,0.04858988],"study_design_scores_gemma":[0.009253587,0.009624937,0.9542549,0.0002546051,0.0006089117,0.001083966,0.0003266811,0.001025268,0.0009850734,0.001094783,0.02142534,0.00006190073],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9672975,0.001953867,0.001902035,0.00093372,0.0001600053,0.001424132,0.02282721,0.00005250745,0.003449026],"genre_scores_gemma":[0.9767559,0.0004252709,0.002101766,0.001532747,0.0002172353,0.005565665,0.01072061,0.00003874734,0.002642039],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006707469,"threshold_uncertainty_score":0.0224387,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4312093562","doi":"10.1111/dom.14949","title":"<scp>IMpact</scp> of flash glucose Monitoring in <scp>pEople</scp> with type 2 Diabetes Inadequately controlled with non‐insulin Antihyperglycaemic <scp>ThErapy</scp> ( <scp>IMMEDIATE</scp> ): A randomized controlled trial","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Abbott Diabetes Care","keywords":"Medicine; Randomized controlled trial; Type 2 diabetes; Diabetes mellitus; Insulin; Internal medicine; Blood Glucose Self-Monitoring; Diabetes management; Endocrinology; Glycemic; Continuous glucose monitoring","authors":[{"name":"Ronnie Aronson","is_ca":true},{"name":"Ruth E. Brown","is_ca":true},{"name":"Lisa Chu","is_ca":true},{"name":"Harpreet S. Bajaj","is_ca":true},{"name":"Hasnain Khandwala","is_ca":true},{"name":"Alexander Abitbol","is_ca":true},{"name":"Nadia Malakieh","is_ca":true},{"name":"Ronald Goldenberg","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01041067646541528,"gpt":0.2465275876684618,"spread":0.2361169112030465,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001692869,0.0008703641,0.00168815,0.0003114532,0.0003681543,0.0008030969,0.0006248769,0.001615613,0.007191057],"category_scores_gemma":[0.002431164,0.0003717822,0.002391872,0.0003951947,0.0006594817,0.0005053498,0.0003784965,0.001951656,0.0004515589],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005053,"about_ca_system_score_gemma":0.0009855879,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001502304,"about_ca_topic_score_gemma":0.002619433,"domain_scores_codex":[0.9991546,0.0004413709,0.0000903329,0.0001292987,0.0000909814,0.00009350351],"domain_scores_gemma":[0.9983225,0.000628558,0.0005185233,0.00007861611,0.00009952898,0.0003522008],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9708692,0.00427505,0.002090807,0.001489083,0.001494076,0.00002902383,0.00003065498,0.000179515,0.0005694567,0.00006495747,0.0005656478,0.01834266],"study_design_scores_gemma":[0.9309259,0.06033587,0.006211166,0.000144227,0.001392303,0.00002863213,0.00002477789,0.0002781219,0.0002240492,0.00007135824,0.0003536983,0.000009851096],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9875469,0.005382151,0.0002740918,0.0007076701,0.0004076996,0.002757021,0.0008539127,0.00005467061,0.002015959],"genre_scores_gemma":[0.991028,0.002643075,0.0008922747,0.0007447617,0.0004914862,0.002451839,0.0006408865,0.000006435627,0.001101214],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007191057,"threshold_uncertainty_score":0.02405649,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2065380980","doi":"10.1111/j.1463-1326.2012.01602.x","title":"Study of Once Daily Levemir (SOLVE™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice","year":2012,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Royal Victoria Hospital","funders":"Novo Nordisk","keywords":"Medicine; Insulin; Insulin detemir; Metformin; Diabetes mellitus; Internal medicine; Observational study; Type 2 Diabetes Mellitus; Type 2 diabetes; Cohort; Basal insulin; Endocrinology","authors":[{"name":"Kamlesh Khunti","is_ca":false},{"name":"Taner Damcı","is_ca":false},{"name":"Luigi Meneghini","is_ca":false},{"name":"Changyu Pan","is_ca":false},{"name":"J.‐F. Yale","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0226503599438302,"gpt":0.2920628943480877,"spread":0.2694125344042576,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003409584,0.000269585,0.0007348373,0.0008238708,0.0002828664,0.00105746,0.0004774509,0.0007707414,0.001360407],"category_scores_gemma":[0.007400447,0.0003919913,0.0007281778,0.001961385,0.0002361658,0.0008466795,0.0005434873,0.0006681767,0.0003183611],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003853565,"about_ca_system_score_gemma":0.0005052983,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00144479,"about_ca_topic_score_gemma":0.002058506,"domain_scores_codex":[0.9976666,0.001048847,0.0003568082,0.0004778627,0.0003199592,0.0001300501],"domain_scores_gemma":[0.9894937,0.002491671,0.006432954,0.0003851365,0.0004340551,0.0007624544],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002938139,0.0001159796,0.9860719,0.0001643857,0.000350648,0.00004712059,0.0001437728,0.00005970427,0.0002425783,0.00003327911,0.0001393066,0.009693187],"study_design_scores_gemma":[0.0001334608,0.001339435,0.9966107,0.00006019758,0.0002154809,0.0002521491,0.0001813392,0.0004314023,0.0001313901,0.00005170466,0.0005809761,0.00001184985],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930641,0.004498381,0.000505721,0.0001625266,0.00002682652,0.00005519779,0.0009332874,0.00001252219,0.000741344],"genre_scores_gemma":[0.9974428,0.0007527057,0.0007325585,0.0001495174,0.00004697973,0.00004876195,0.0005683371,0.000005684127,0.0002525679],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003409584,"threshold_uncertainty_score":0.01803178,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4302292984","doi":"10.1111/dom.14890","title":"Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: <scp>STEP</scp> 1 and 4 exploratory analyses","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Novo Nordisk","keywords":"Medicine; Overweight; Semaglutide; Obesity; Internal medicine; Gerontology; Type 2 diabetes; Endocrinology; Diabetes mellitus; Liraglutide","authors":[{"name":"Mikhail Kosiborod","is_ca":false},{"name":"Meena Bhatta","is_ca":false},{"name":"Melanie J. Davies","is_ca":false},{"name":"John Deanfield","is_ca":false},{"name":"W. Timothy Garvey","is_ca":false},{"name":"Usman Khalid","is_ca":false},{"name":"Robert F. Kushner","is_ca":false},{"name":"Domenica Rubino","is_ca":false},{"name":"Niels Zeuthen","is_ca":false},{"name":"Subodh Verma","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01407557913942847,"gpt":0.2354850065829325,"spread":0.2214094274435041,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002048674,0.0009362485,0.001645345,0.0003467909,0.0002074046,0.0007982262,0.0003576676,0.0004836932,0.004152874],"category_scores_gemma":[0.001712182,0.0002639659,0.003553642,0.0003513984,0.0002067477,0.000396061,0.0004682768,0.0008025886,0.0003703416],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003754193,"about_ca_system_score_gemma":0.000989734,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007497901,"about_ca_topic_score_gemma":0.0033911,"domain_scores_codex":[0.9994001,0.0003055403,0.00007477839,0.0000646805,0.00007786764,0.00007695401],"domain_scores_gemma":[0.999109,0.0002745379,0.0002725581,0.0000672942,0.0001163071,0.0001602488],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7005426,0.007060632,0.08491602,0.006886234,0.04546203,0.0003152241,0.0002025686,0.003170782,0.01453247,0.0002498729,0.004250565,0.132411],"study_design_scores_gemma":[0.3608112,0.200066,0.3786344,0.000999473,0.04175219,0.000582916,0.0002268558,0.003796513,0.007412798,0.0007977172,0.004799861,0.0001202141],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897971,0.004583724,0.0004216029,0.0002763218,0.00004428613,0.001103227,0.002162028,0.00007683518,0.001534953],"genre_scores_gemma":[0.9902474,0.002362371,0.001843515,0.0003291507,0.00005933372,0.001447934,0.002372836,0.00001792657,0.001319392],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004152874,"threshold_uncertainty_score":0.01389271,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2611973976","doi":"10.1111/dom.12963","title":"Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"National Center for Advancing Translational Sciences; Novo Nordisk","keywords":"Medicine; Liraglutide; Randomized controlled trial; Phase (matter); Weight management; Internal medicine; Weight loss; Type 2 diabetes; Endocrinology; Diabetes mellitus; Obesity","authors":[{"name":"Patrick M. O’Neil","is_ca":false},{"name":"Vanita R. Aroda","is_ca":false},{"name":"Arne Astrup","is_ca":false},{"name":"Robert F. Kushner","is_ca":false},{"name":"David C.W. Lau","is_ca":true},{"name":"Thomas A. Wadden","is_ca":false},{"name":"Jason Brett","is_ca":false},{"name":"Ana‐Paula Cancino","is_ca":false},{"name":"John Wilding","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01417755314538457,"gpt":0.2715340415970856,"spread":0.257356488451701,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0080575,0.001236184,0.003329824,0.0007261715,0.0003662584,0.001539031,0.0007755894,0.001729587,0.003417243],"category_scores_gemma":[0.009662338,0.0004413947,0.006425496,0.0009874866,0.0009583347,0.0008896857,0.0003361332,0.001579372,0.0003912208],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000949011,"about_ca_system_score_gemma":0.001281462,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008097991,"about_ca_topic_score_gemma":0.002135849,"domain_scores_codex":[0.9961841,0.002300376,0.0006428324,0.0003641631,0.000359336,0.0001492003],"domain_scores_gemma":[0.9928254,0.002681174,0.003312943,0.0003375813,0.0005043807,0.0003384174],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7884519,0.002177056,0.004717269,0.02484399,0.04154696,0.0001507667,0.0001481025,0.0006996966,0.004362675,0.0002994319,0.003948661,0.1286536],"study_design_scores_gemma":[0.8576753,0.06551656,0.02281148,0.003489365,0.04234936,0.0003123965,0.00008683695,0.0006018977,0.001558095,0.0007477733,0.004762563,0.00008839391],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4923061,0.4865198,0.002871508,0.003202156,0.0009934604,0.004702218,0.004231338,0.0003590774,0.004814348],"genre_scores_gemma":[0.8743904,0.1112421,0.002757751,0.003483621,0.0009747772,0.003631417,0.002411583,0.00005610182,0.001052244],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0080575,"threshold_uncertainty_score":0.04261267,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1985422490","doi":"10.1111/j.1463-1326.2009.01131.x","title":"Multiple molecular targets underlie the antidiabetic effect of <i>Nigella sativa</i> seed extract in skeletal muscle, adipocyte and liver cells","year":2009,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Nigella sativa pharmacological applications","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Nigella sativa; AMPK; Adipocyte; Skeletal muscle; Glucose uptake; Internal medicine; Endocrinology; Insulin; Biology; Protein kinase B; Lipid droplet; Protein kinase A; Pharmacology; Biochemistry; Signal transduction; Adipose tissue; Kinase; Medicine; Traditional medicine","authors":[{"name":"Ali Benhaddou-Andaloussi","is_ca":true},{"name":"Louis C. Martineau","is_ca":true},{"name":"Diane Vallerand","is_ca":true},{"name":"Yara K. Haddad","is_ca":true},{"name":"Ahmadreza Afshar","is_ca":true},{"name":"Abdellatif Settaf","is_ca":false},{"name":"Pierre S. Haddad","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006363705254914752,"gpt":0.2352502699697273,"spread":0.2288865647148126,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007011132,0.0004488484,0.0003134359,0.0002510833,0.0002231034,0.0002369414,0.0002472037,0.0003967499,0.002255978],"category_scores_gemma":[0.00004426574,0.0001205684,0.0004952356,0.0001644887,0.0001795999,0.0002349332,0.0001835371,0.0004116189,0.0003878285],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002781174,"about_ca_system_score_gemma":0.0002170381,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008552435,"about_ca_topic_score_gemma":0.001784502,"domain_scores_codex":[0.9999514,0.000005508177,0.000004780123,0.00001214901,0.00001250545,0.00001366851],"domain_scores_gemma":[0.9999597,0.000004326671,0.00001696511,0.000003464216,0.000009148196,0.00000642769],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003606663,0.00004551017,0.0005206021,0.0002231339,0.00002399088,0.0001960861,0.00001449152,0.00003503523,0.995863,0.0001163164,0.00007255586,0.002528565],"study_design_scores_gemma":[0.0001277267,0.00136666,0.09325288,0.0000629406,0.0001749371,0.001039201,0.0001176847,0.0005269721,0.8965248,0.0003096556,0.0064801,0.00001639611],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9787001,0.01221796,0.003243209,0.0004791536,0.00006347802,0.00005680693,0.0006647009,0.0001960913,0.004378509],"genre_scores_gemma":[0.9892971,0.004214249,0.001826331,0.0002161847,0.0000260109,0.00004741893,0.0009330675,0.00001568137,0.003423954],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002255978,"threshold_uncertainty_score":0.007547021,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2950136952","doi":"10.1111/dom.13811","title":"Sodium‐glucose co‐transporter inhibitors, their role in type 1 diabetes treatment and a risk mitigation strategy for preventing diabetic ketoacidosis: The STOP DKA Protocol","year":2019,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Manitoba Health; Lunenfeld-Tanenbaum Research Institute; Health Sciences Centre; St Joseph's Health Care; University of Toronto; Western University; Sunnybrook Health Science Centre; LMC Diabetes & Endocrinology (Canada)","funders":"Sanofi; AstraZeneca","keywords":"Medicine; Empagliflozin; Diabetic ketoacidosis; Dapagliflozin; Diabetes mellitus; Type 2 diabetes; Type 1 diabetes; Insulin; Canagliflozin; Intensive care medicine; Internal medicine; Endocrinology","authors":[{"name":"Ronald Goldenberg","is_ca":true},{"name":"Jeremy Gilbert","is_ca":true},{"name":"Irene Hramiak","is_ca":true},{"name":"Vincent Woo","is_ca":true},{"name":"Bernard Zinman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02631536511154119,"gpt":0.2924846575457922,"spread":0.266169292434251,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002436084,0.0007445734,0.001182347,0.001339421,0.0002201976,0.0007008146,0.001051223,0.001313843,0.003925895],"category_scores_gemma":[0.002082162,0.0002292519,0.001436158,0.0008939902,0.0003195848,0.0009924698,0.0008011051,0.002167501,0.001348407],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007799924,"about_ca_system_score_gemma":0.003139426,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001176396,"about_ca_topic_score_gemma":0.002452026,"domain_scores_codex":[0.9993299,0.0002442014,0.0001634137,0.0000409712,0.0001831209,0.00003832677],"domain_scores_gemma":[0.9993696,0.0002677999,0.0001517182,0.00002128196,0.0001412446,0.00004830994],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007819278,0.0002443808,0.0001161837,0.07048704,0.0003026288,0.00009751938,0.00005438906,0.0002830852,0.001364903,0.005528647,0.05610103,0.8646383],"study_design_scores_gemma":[0.001185926,0.0005461943,0.002117846,0.0496814,0.001081206,0.0004361958,0.00004911559,0.0001785677,0.0008645782,0.003081682,0.9407429,0.00003438435],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"protocol","genre_scores_codex":[0.001246937,0.9802324,0.001271482,0.004758144,0.001960812,0.001943491,0.0007024021,0.00005481196,0.007829609],"genre_scores_gemma":[0.003566123,0.9793946,0.004258226,0.004642125,0.0004329613,0.002079748,0.001197847,0.00001391546,0.004414523],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.003925895,"threshold_uncertainty_score":0.01313341,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}